Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Passweg Jakob R.

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.

Chalandon Y; Sbianchi G; Gras L; Koster L; Apperley J; Byrne J; Salmenniemi U; Sengeloev H; Aljurf M; Helbig G; Kinsella F; Choi G; Reményi P; Snowden JA; Robin M; Lenhoff S; Mielke S; Passweg J; Broers AEC; Kröger N; Yegin ZA; Tan SM; Hayden PJ; McLornan DP; Yakoub-Agha I; Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT). American journal of hematology. 2023.

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates.

Sava M; Bättig V; Gerull S; Passweg JR; Khanna N; Garzoni C; Gerber B; Mueller NJ; Schanz U; Berger C; Chalandon Y; van Delden C; Neofytos D; Stampf S; Franzeck FC; Weisser M; Swiss Transplant Cohort Study. . 2023.

Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).

Bänziger S; Weisshaar K; Arokoski R; Gerull S; Halter J; Rovó A; Bargetzi M; Goede JS; Senft Y; Valenta S; Passweg JR; Drexler B. Annals of hematology. 2023.

Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy.

Dertschnig S; Gergely P; Finke J; Schanz U; Holler E; Holtick U; Socié G; Medinger M; Passweg J; Teshima T; Stylianou C; Oehen S; Heim D; Bucher C. Transplantation and cellular therapy. 2023.

20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.

Bazarbachi A; Labopin M; Aljurf M; Niittyvuopio R; Balsat M; Blaise D; Yakoub-Agha I; Grassi A; Reinhardt HC; Lenhoff S; Jindra P; Passweg J; Abou Dalle I; Stadler M; Lioure B; Ceballos P; Brissot E; Giebel S; Nagler A; Schmid C; Mohty M. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022.

Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT.

Nabergoj M; Mauff K; Beelen D; Ganser A; Kröger N; Stölzel F; Finke J; Passweg J; Cornelissen J; Schub N; Veelken JH; Beguin Y; Wilson K; Zuckerman T; Hunault-Berger M; Lioure B; Porras RP; Turlure P; Kerre T; Koster L; Hayden PJ; Onida F; Scheid C; Chalandon Y; Robin M; Yakoub-Agha I. Bone Marrow Transplantation. 2022.

Antibody response to mRNA SARS-CoV-2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation.

Beerlage A; Leuzinger K; Valore L; Mathew R; Junker T; Drexler B; Passweg JR; Hirsch HH; Halter J. Transplant infectious disease : an official journal of the Transplantation Society. 2022.

Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.

Drozd-Sokołowska J; Gras L; Zinger N; Snowden JA; Arat M; Basak G; Pouli A; Crawley C; Wilson KMO; Tilly H; Byrne J; Bulabois CE; Passweg J; Ozkurt ZN; Schroyens W; Lioure B; Colorado Araujo M; Poiré X; Van Gorkom G; Gurman G; de Wreede LC; Hayden PJ; Beksac M; Schönland SO; Yakoub-Agha I. Bone Marrow Transplantation. 2022.

Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.

Rüesch M; Amar El Dusouqui S; Buhrfeind E; Buser A; Chalandon Y; Frey BM; Güngör T; Holbro A; Huguet S; Infanti L; Nair G; Nicoloso G; Passweg JR; Schanz U; Tiercy JM; Widmer I; Zeilhofer U; Zurkinden L; Halter JP. Bone Marrow Transplantation. 2022.

CB-103: A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: A case report of complete clinical response in a patient with relapsed and refractory T-ALL.

Medinger M; Junker T; Heim D; Tzankov A; Jermann PM; Bobadilla M; Vigolo M; Lehal R; Vogl FD; Bauer M; Passweg J. . 2022.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.

Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M. Bone Marrow Transplantation. 2022.

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.

Raj K; Eikema DJ; Sheth V; Koster L; de Wreede LC; Blaise D; Di Grazia C; Koc Y; Potter V; Chevallier P; Lopez-Corral L; Wu D; Mielke S; Maertens J; Meijer E; Huynh A; Passweg J; Luft T; Pérez-Simón JA; Ciceri F; Piekarska A; Hayri Ozsan G; Kröger N; Robin M; Yakoub-Agha I. Blood Cancer Journal. 2022.

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis.

Tettero JM; Al-Badri WKW; Ngai LL; Bachas C; Breems DA; van Elssen CHMJ; Fischer T; Gjertsen BT; van Gorkom GNY; Gradowska P; Greuter MJE; Griskevicius L; Juliusson G; Maertens J; Manz MG; Pabst T; Passweg J; Porkka K; Löwenberg B; Ossenkoppele GJ; Janssen JJWM; Cloos J. Frontiers in oncology. 2022.

Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.

Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC. Current oncology (Toronto, Ont.). 2022.

Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.

Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M. . 2022.

Correction to: Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT).

Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De La Fuente J; Höchsmann B; Osman Ahmed S; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja MA; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry QU; Ljungman P; Marsh J; El Fakih R; Aljurf M; Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT). . 2022.

Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.

Vincent L; Gras L; Ceballos P; Finke J; Passweg J; Harel S; Rosinol L; Minnema M; Teipel R; van Doesum J; Hänel M; Lenain P; Botella-Garcia C; Koenecke C; Ducastelle S; Sanz J; Schroyens W; Zuckerman T; Monaco F; Koster L; de Wreede L; Hayden PJ; Schönland S; Yakoub-Agha I; Beksac M. . 2022.

Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients

Kusejko K.; Chammartin F.; Smith D.; Odermatt M.; Schuhmacher J.; Koller M.; Gunthard H.F.; Briel M.; Bucher H.C.; Speich B.; Abela I.; Aebi-Popp K.; Anagnostopoulos A.; Battegay M.; Bernasconi E.; Braun D.L.; Bucher H.C.; Calmy A.; Cavassini M.; Ciuffi A.; Dollenmaier G.; Egger M.; Elzi L.; Fehr J.; Fellay J.; Furrer H.; Fux C.A.; Gunthard H.F.; Hachfeld A.; Haerry D.; Hasse B.; Hirsch H.H.; Hoffmann M.; Hosli I.; Huber M.; Kahlert C.R.; Kaiser L.; Keiser O.; Klimkait T.; Kouyos R.D.; Kovari H.; Kusejko K.; Martinetti G.; Martinez de Tejada B.; Marzolini C.; Metzner K.J.; Muller N.; Nemeth J.; Nicca D.; Paioni P.; Pantaleo G.; Perreau M.; Rauch A.; Schmid P.; Speck R.; Stockle M.; Tarr P.; Trkola A.; Wandeler G.; Yerly S.; Amico P.; Aubert J.-D.; Banz V.; Beckmann S.; Beldi G.; Berger C.; Berishvili E.; Berzigotti A.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Catana E.; Cairoli A.; Chalandon Y.; De Geest S.; De Rougemont O.; De Seigneux S.; Dickenmann M.; Dreifuss J.L.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Golshayan D.; Goossens N.; Halter F.H.J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hirt P.; Hofbauer G.; Huynh-Do U.; Immer F.; Laager M.; Laesser B.; Lamoth F.; Lehmann R.; Leichtle A.; Manuel O.; Marti H.-P.; Martinelli M.; McLin V.; Mellac K.; Mercay A.; Mettler K.; Muller A.; Mueller N.J.; Muller-Arndt U.; Mullhaupt B.; Nageli M.; Oldani G.; Pascual M.; Passweg J.; Pazeller R.; Posfay-Barbe K.; Rick J.; Rosselet A.; Rossi S.; Rothlin S.; Ruschitzka F.; Schachtner T.; Schanz U.; Schaub S.; Scherrer A.; Schnyder A.; Schuurmans M.; Schwab S.; Sengstag T.; Simonetta F.; Stampf S.; Steiger J.; Stirnimann G.; Sturzinger U.; Van Delden C.; Venetz J.-P.; Villard J.; Vionnet J.; Wick M.; Wilhelm M.; Yerly P.. BMC INFECTIOUS DISEASES. 2022.

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.

Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. The New England journal of medicine. 2022.

Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients

Pham T.-T.; Andrey D.O.; Stampf S.; Burkhard S.; Hirzel C.; Tschopp J.; Ullrich K.; Strahm C.; Schreiber P.W.; Boillat-Blanco N.; Garzoni C.; Khanna N.; Manuel O.; Mueller N.J.; Suva D.; van Delden C.; Uckay I.; Neofytos D.; Amico P.; Axel A.; Aubert J.-D.; Banz V.; Beckmann S.; Beldi G.; Berger C.; Berishvili E.; Berzigotti A.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Catana E.; Cairoli A.; Chalandon Y.; De Geest S.; De Rougemont O.; De Seigneux S.; Dickenmann M.; Dreifuss J.L.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Golshayan D.; Goossens N.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hirt P.; Hofbauer G.; Huynh-Do U.; Immer F.; Koller M.; Laager M.; Laesser B.; Lamoth F.; Lehmann R.; Leichtle A.; Marti H.-P.; Martinelli M.; McLin V.; Mellac K.; Mercay A.; Mettler K.; Muller A.; Muller-Arndt U.; Mullhaupt B.; Nageli M.; Oldani G.; Pascual M.; Passweg J.; Pazeller R.; Posfay-Barbe K.; Rick J.; Rosselet A.; Rossi S.; Rothlin S.; Ruschitzka F.; Schachtner T.; Schanz U.; Schaub S.; Scherrer A.; Schnyder A.; Schuurmans M.; Schwab S.; Sengstag T.; Simonetta F.; Steiger J.; Stirnimann G.; Sturzinger U.; Venetz J.-P.; Villard J.; Vionnet J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2022.

External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study.

Fattinger N; Roth JA; Baldomero H; Stolz D; Medinger M; Heim D; Tamm M; Halter JP; Passweg JR; Kleber M. HemaSphere. 2022.

Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.

Shumilov E; Shakhanova I; Flach J; Schmidt N; Buerki S; Legros M; Kronig MN; Ofran Y; Gerull S; Medinger M; Taleghani BM; Passweg J; Halter J; Bacher U; Pabst T. Bone Marrow Transplantation. 2022.

Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation.

Bräutigam M; Volken T; Plattner A; Passweg JR; Halter JP; Drexler B; Heim D; Schaub S; Buser AS; Infanti L; Holbro A. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2022.

HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party

Mikulska M.; Penack O.; Wendel L.; Knelange N.; Cornelissen J.J.; Blijlevens N.; Passweg J.; Kroger N.; Bruns A.; Koenecke C.; Bierings M.; Pinana J.L.; Labussiere-Wallet H.; Ghesquieres H.; Diaz M.A.; Sampol A.; Averbuch D.; de la Camara R.; Styczynski J.. Bone marrow transplantation. 2022.

Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.

Forestieri G; Terzi di Bergamo L; Deodato M; Frustaci AM; Moia R; Deambrogi C; Rasi S; Autore F; Merli M; Mattarucchi R; Fahrni G; Scarfo' L; Gussetti D; Bulian P; Zanatta A; Spina V; Bruscaggin A; Pini K; Piffaretti D; Pirosa MC; Salehi M; Marques de Almeida J; Passweg J; Cavalli F; Zucca E; Gerber B; Stussi G; Gattei V; Ghia P; Gregor M; Passamonti F; Laurenti L; Gaidano G; Tedeschi A; Rossi D; Condoluci A. . 2022.

Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantation.

Seydoux C; Battegay R; Halter J; Heim D; Rentsch KM; Passweg JR; Medinger M. Bone Marrow Transplantation. 2022.

Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.

Passweg JR; Baldomero H; Chabannon C; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; Mohty M; Neven B; Peffault de Latour R; Perić Z; Snowden JA; Yakoub-Agha I; Sureda A; Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2022.

Indices of iron homeostasis in asymptomatic subjects with HFE mutations and moderate ferritin elevation during iron removal treatment.

Infanti L; Leitner G; Moe MK; Pehlic V; Benkert P; Cattaneo M; Holbro A; Passweg J; Worel N; Buser A. Blood cells, molecules & diseases. 2022.

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Nagler A; Ngoya M; Galimard JE; Labopin M; Bornhäuser M; Stelljes M; Finke J; Ganser A; Einsele H; Kröger N; Brecht A; Bethge W; Edinger M; Kulagin A; Passweg J; Blau IW; Elmaagacli A; Schäfer-Eckart K; Platzbecker U; Schroeder T; Bunjes D; Tischer J; Martin S; Spyridonidis A; Giebel S; Savani B; Mohty M. . 2022.

Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.

Stutz L; Halter JP; Heim D; Passweg JR; Medinger M. Bone Marrow Transplantation. 2022.

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

Buske C; Dreyling M; Alvarez-Larrán A; Apperley J; Arcaini L; Besson C; Bullinger L; Corradini P; Giovanni Della Porta M; Dimopoulos M; D'Sa S; Eich HT; Foà R; Ghia P; da Silva MG; Gribben J; Hajek R; Harrison C; Heuser M; Kiesewetter B; Kiladjian JJ; Kröger N; Moreau P; Passweg JR; Peyvandi F; Rea D; Ribera JM; Robak T; San-Miguel JF; Santini V; Sanz G; Sonneveld P; von Lilienfeld-Toal M; Wendtner C; Pentheroudakis G; Passamonti F. ESMO Open. 2022.

Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).

Maffini E; Labopin M; Beelen DW; Kroeger N; Arat M; Wilson KMO; Bay JO; Ganser A; Martin H; Passweg J; Kottaridis PD; Yakoub-Agha I; Porras RP; Wagner EM; Esteve J; Lanza F; Nagler A; Mohty M. Bone Marrow Transplantation. 2022.

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

Niederwieser D; Baldomero H; Bazuaye N; Bupp C; Chaudhri N; Corbacioglu S; Elhaddad A; Frutos C; Galeano S; Hamad N; Hamidieh AA; Hashmi S; Ho A; Horowitz MM; Iida M; Jaimovich G; Karduss A; Kodera Y; Kröger N; Péffault de Latour R; Lee JW; Martínez-Rolón J; Pasquini MC; Passweg J; Paulson K; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Koh MBC; Aljurf M; Greinix H; Atsuta Y; Saber W. Haematologica. 2022.

Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study.

Héritier J; Medinger M; Heim D; Baldomero H; Arranto C; Halter JP; Passweg JR; Kleber M. Bone Marrow Transplantation. 2022.

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

Masouridi-Levrat S.; Olavarria E.; Iacobelli S.; Aljurf M.; Morozova E.; Niittyvuopio R.; Sengeloev H.; Remenyi P.; Helbig G.; Browne P.; Ganser A.; Nagler A.; Snowden J.A.; Robin M.; Passweg J.; Van Gorkom G.; Wallet H.L.; Hoek J.; Blok H.-J.; De Witte T.; Kroeger N.; Hayden P.; Chalandon Y.; Agha I.Y.. Bone marrow transplantation. 2022.

Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis.

Kirsch M; Stehle GT; Konantz M; Passweg J; Dirnhofer S; Meyer SC; Hartmann K. Journal of Allergy and Clinical Immunology: In Practice. 2022.

Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.

Onida F; Sbianchi G; Radujkovic A; Sockel K; Kröger N; Sierra J; Socié G; Cornelissen J; Poiré X; Raida L; Bourhis JH; Finke J; Passweg J; Salmenniemi U; Schouten HC; Beguin Y; Martin S; Deconinck E; Ganser A; Zver S; Lioure B; Rohini R; Koster L; Hayden P; Iacobelli S; Robin M; Yakoub-Agha I. Bone Marrow Transplantation. 2022.

Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study

Schreiber P.W.; Laager M.; Boggian K.; Neofytos D.; Van Delden C.; Egli A.; Dickenmann M.; Hirzel C.; Manuel O.; Koller M.; Rossi S.; Schmied B.; Gurke L.; Matter M.; Berney T.; De Rougemont O.; Kuster S.P.; Stampf S.; Mueller N.J.; Amico P.; Aubert J.-D.; Banz V.; Beckmann S.; Beldi G.; Berger C.; Berishvili E.; Berzigotti A.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Catana E.; Cairoli A.; Chalandon Y.; De Geest S.; De Seigneux S.; Dreifuss J.L.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Golshayan D.; Goossens N.; Halter F.H.J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hirt P.; Hofbauer G.; Huynh-Do U.; Immer F.; Laesser B.; Lamoth F.; Lehmann R.; Leichtle A.; Marti H.P.; Martinelli M.; McLin V.; Mellac K.; Mercay A.; Mettler K.; Muller A.; Muller-Arndt U.; Mullhaupt B.; Nageli M.; Oldani G.; Pascual M.; Passweg J.; Pazeller R.; Posfay-Barbe K.; Rick J.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schachtner T.; Schanz U.; Schaub S.; Scherrer A.; Schnyder A.; Schuurmans M.; Schwab S.; Sengstag T.; Simonetta F.; Steiger J.; Stirnimann G.; Sturzinger U.; Venetz J.-P.; Villard J.; Vionnet J.; Wick M.; Wilhelm M.; Yerly P.. Journal of Hospital Infection. 2022.

The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed.

Bakunina K; Putter H; Versluis J; Koster EAS; van der Holt B; Manz MG; Breems DA; Gjertsen BT; Cloos J; Valk PJM; Passweg J; Pabst T; Ossenkoppele GJ; Löwenberg B; Cornelissen JJ; de Wreede LC. Cancer medicine. 2022.

Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series.

Dalla Via V; Stelmes A; Recher M; Arranto C; Junker T; Matteazzi F; Heim D; Passweg JR; Medinger M; van den Berg J. . 2022.

Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.

Alotaibi H; Aljurf M; de Latour R; Alfayez M; Bacigalupo A; Fakih RE; Schrezenmeier H; Ahmed SO; Gluckman E; Iqbal S; Höchsmann B; Halkes C; de la Fuente J; Alshehry N; Cesaro S; Passweg J; Dufour C; Risitano AM; DiPersio J; Motabi I. Transplantation and cellular therapy. 2022.

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: The HOVON-SAKK-132 trial

Lowenberg B.; Pabst T.; Maertens J.; Gradowska P.; Biemond B.J.; Spertini O.; Vellenga E.; Griskevicius L.; Tick L.W.; Jongen-Lavrencic M.; Kooy M.V.M.; Vekemans M.-C.; Van Der Velden W.J.F.M.; Beverloo B.; Michaux L.; Graux C.; Deeren D.; Weerdt O.D.; Esser J.W.J.V.; Klein M.B.S.K.; Gadisseur A.; Westerweel P.E.; Veelken H.; Gregor M.; Silzle T.; Lammeren-Venema D..V.; Moors I.; Breems D.A.; Hoogendoorn M.; Legdeur M.-C.J.C.; Fischer T.; Kuball J.; Porkka J.C.K.; Juliusson G.; Meyer P.; Hoglund M.; Gjertsen B.T.; Janssen J.J.W.M.; Huls G.; Passweg J.; Cloos J.; Valk P.J.M.; Elssen C.H.M.J.V.; Manz M.G.; Floisand Y.; Ossenkoppele G.J.. Blood advances. 2021.

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.

Buhler S; Baldomero H; Ferrari-Lacraz S; Mamez AC; Masouridi-Levrat S; Heim D; Halter J; Nair G; Chalandon Y; Schanz U; Güngör T; Nicoloso G; Passweg JR; Villard J; Swiss Blood Stem Cell Transplantation Group. Blood advances. 2021.

An ounce of which prevention is worth a…?

Halter J; Passweg J. Blood. 2021.

Antenatal predictors of stem cell content for successful umbilical cord blood donation

Funk A.; Buechel J.; Huhn E.A.; Mueller D.; Granado C.; Tsakiris D.; Schoetzau A.; Passweg J.; Hoesli I.; Manegold-Brauer G.. Archives of gynecology and obstetrics. 2021.

Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.

Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J. International journal of laboratory hematology. 2021.

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial.

Seydoux C; Medinger M; Gerull S; Halter J; Heim D; Chalandon Y; Levrat SM; Schanz U; Nair G; Ansari M; Simon P; Passweg JR; Cantoni N. Annals of hematology. 2021.

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma.

Tschan-Plessl A; Kalberer CP; Wieboldt R; Stern M; Siegler U; Wodnar-Filipowicz A; Gerull S; Halter J; Heim D; Tichelli A; Tsakiris DA; Malmberg KJ; Passweg JR; Bottos A. Cytotherapy. 2021.

Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.

Kraljevic M; Khanna N; Medinger M; Passweg J; Masouridi-Levrat S; Chalandon Y; Mueller NJ; Schanz U; Vernaz N; Van Delden C; Neofytos D; Swiss Transplant Cohort Study. MEDICAL MYCOLOGY. 2021.

Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit

Gratwohl A.; Passweg J.; Baldomero H.; Orchard K.; Kroger N.; Snowden J.A.. British Journal of Haematology. 2021.

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey (Bone Marrow Transplantation, (2020), 55, 12, (2335-2338), 10.1038/s41409-020-0946-x)

Sellner L.; Schetelig J.; Koster L.; Choi G.; Blaise D.; Beelen D.; Schianca F.C.; Passweg J.; Schanz U.; Gyan E.; Sora F.; Kroger N.; Wulf G.G.; Van Gorkom G.; Mayer J.; Orvain C.; Bourhis J.H.; Jindra P.; Potter V.; Zallio F.; Vandenberghe E.; Robinson S.; Hayden P.J.; Yakoub-Agha I.; Montoto S.; Dreger P.. Bone marrow transplantation. 2021.

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.

Percival ME; Wang HL; Zhang MJ; Saber W; de Lima M; Litzow M; Kebriaei P; Abdel-Azim H; Adekola K; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bejanyan N; Bhatt V; Byrne M; Cahn JY; Castillo P; Chao N; Chhabra S; Copelan E; Cutler C; DeFilipp Z; Dias A; Diaz MA; Estey E; Farhadfar N; Frangoul HA; Freytes CO; Gale RP; Ganguly S; Gowda L; Grunwald M; Hossain N; Kamble RT; Kanakry CG; Kansagra A; Kharfan-Dabaja MA; Krem M; Lazarus HM; Lee JW; Liesveld JL; Lin R; Liu H; McGuirk J; Munker R; Murthy HS; Nathan S; Nishihori T; Olsson RF; Palmisiano N; Passweg JR; Prestidge T; Ringdén O; Rizzieri DA; Rybka WB; Savoie ML; Schultz KR; Seo S; Sharma A; Solh M; Strair R; van der Poel M; Verdonck LF; Yared JA; Weisdorf D; Sandmaier BM. . 2021.

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA; EPICOVIDEHA working group.. Journal of Hematology & Oncology. 2021.

Current evidence and the emerging role of eltrombopag in severe aplastic anemia

Drexler B.; Passweg J.. Therapeutic Advances in Hematology. 2021.

Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation.

Hernández-Boluda JC; Pereira A; Kröger N; Beelen D; Robin M; Bornhäuser M; Angelucci E; Vitek A; Blau IW; Niittyvuopio R; Finke J; Cornelissen JJ; Passweg J; Dreger P; Petersen E; Kanz L; Sanz J; Zuckerman T; Zinger N; Iacobelli S; Hayden P; Czerw T; McLornan D; Yakoub-Agha I. Leukemia. 2021.

Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth—the SMILe study

Leppla L.; Schmid A.; Valenta S.; Mielke J.; Beckmann S.; Ribaut J.; Teynor A.; Dobbels F.; Duerinckx N.; Zeiser R.; Engelhardt M.; Gerull S.; De Geest S.; Bolliger D.; Chalandon Y.; De DGeest S.; Degen S.; Furmann M.; Grossmann F.; Hasemann M.; Heidegger P.; Hermann A.; Hobelsberger S.; Husel M.; Koehly K.; Lemcke M.; Maier B.; Mamez A.-C.; Masouridi S.; Nair G.; Neupert D.; Passweg J.; Pschenitza S.; Reitwiessner S.; Ribaut J.; Rockstein D.; Schanz U.; Schoemans H.; Schulz T.; Schumacher V.; Senft Y.; Werlitz V.; Witzig-Brandli V.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021.

Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?

Seydoux C.; Passweg J.R.; Medinger M.. Annals of hematology. 2021.

Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy.

Brkic S; Stivala S; Santopolo A; Szybinski J; Jungius S; Passweg JR; Tsakiris D; Dirnhofer S; Hutter G; Leonards K; Lischer HEL; Dettmer MS; Neel BG; Levine RL; Meyer SC. Leukemia. 2021.

Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.

Brune MM; Stüssi G; Lundberg P; Vela V; Heim D; Manz MG; Haralambieva E; Pabst T; Banz Y; Bargetzi M; Grobholz R; Fehr M; Cogliatti S; Ossenkoppele GJ; Löwenberg B; Rudolf CB; Li Q; Passweg J; Mazzuchelli L; Medinger M; Tzankov A; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Annals of hematology. 2021.

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Passweg J.R.; Baldomero H.; Chabannon C.; Basak G.W.; de la Camara R.; Corbacioglu S.; Dolstra H.; Duarte R.; Glass B.; Greco R.; Lankester A.C.; Mohty M.; Peffault de Latour R.; Snowden J.A.; Yakoub-Agha I.; Kroger N.. Bone marrow transplantation. 2021.

Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions.

Baur K; Buser AS; Infanti L; Halter JP; Passweg JR; Holbro A. The Lancet. Haematology. 2021.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Percival M.-E.; Wang H.-L.; Zhang M.-J.; Saber W.; de Lima M.; Litzow M.; Kebriaei P.; Abdel-Azim H.; Adekola K.; Aljurf M.; Bacher U.; Badawy S.M.; Beitinjaneh A.; Bejanyan N.; Bhatt V.; Byrne M.; Cahn J.-Y.; Castillo P.; Chao N.; Chhabra S.; Copelan E.; Cutler C.; DeFilipp Z.; Dias A.; Diaz M.A.; Estey E.; Farhadfar N.; Frangoul H.A.; Freytes C.O.; Gale R.P.; Ganguly S.; Gowda L.; Grunwald M.; Hossain N.; Kamble R.T.; Kanakry C.G.; Kansagra A.; Kharfan-Dabaja M.A.; Krem M.; Lazarus H.M.; Lee J.W.; Liesveld J.L.; Lin R.; Liu H.; McGuirk J.; Munker R.; Murthy H.S.; Nathan S.; Nishihori T.; Olsson R.F.; Palmisiano N.; Passweg J.R.; Prestidge T.; Ringden O.; Rizzieri D.A.; Rybka W.B.; Savoie M.L.; Schultz K.R.; Seo S.; Sharma A.; Solh M.; Strair R.; van der Poel M.; Verdonck L.F.; Yared J.A.; Weisdorf D.; Sandmaier B.M.. Bone marrow transplantation. 2021.

Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

Kroger N.; Sbianchi G.; Sirait T.; Wolschke C.; Beelen D.; Passweg J.; Robin M.; Vrhovac R.; Helbig G.; Sockel K.; Conneally E.; Rubio M.T.; Beguin Y.; Finke J.; Bernasconi P.; Morozova E.; Clausen J.; von dem Borne P.; Schaap N.; Schroyens W.; Patriarca F.; Di Renzo N.; Yegin Z.A.; Hayden P.; McLornan D.; Yakoub-Agha I.. Leukemia. 2021.

Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).

Polverelli N; Mauff K; Kröger N; Robin M; Beelen D; Beauvais D; Chevallier P; Mohty M; Passweg J; Rubio MT; Maertens J; Finke J; Bornhäuser M; Vrhovac R; Helbig G; Mear JB; Castagna L; Reményi P; Angelucci E; Karakasis D; Rifòn J; Sirait T; Russo D; de Wreede L; Czerw T; Hernández-Boluda JC; Hayden P; McLornan D; Yakoub-Agha I. American journal of hematology. 2021.

Implementation Science Meets Software Development to Create eHealth Components for an Integrated Care Model for Allogeneic Stem Cell Transplantation Facilitated by eHealth: The SMILe Study as an Example

Leppla L.; Hobelsberger S.; Rockstein D.; Werlitz V.; Pschenitza S.; Heidegger P.; De Geest S.; Valenta S.; Teynor A.; Beckmann S.; Bolliger D.; Chalandon Y.; Degen S.; Dobbels F.; Duerinckx N.; Engelhardt M.; Furmann M.; Furmann M.; Gerull S.; Grossmann F.; Hasemann M.; Husel M.; Kelmendi T.; Koehly K.; Krais R.; Lemcke M.; Maier B.; Mamez A.-C.; Masouridi S.; Mielke J.; Nair G.; Neupert D.; Passweg J.; Reitwiessner S.; Ribaut J.; Schanz U.; Schmid A.; Schoemans H.; Schulz T.; Schumacher V.; Senft Y.; Ulrich A.; Witzig-Brandli V.; Zeiser R.. Journal of Nursing Scholarship. 2021.

Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantation

Macy S.; Passweg J.; Medinger M.. Annals of hematology. 2021.

Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantation

Hunziker M.; Passweg J.; Medinger M.. Leukemia Research Reports. 2021.

Lack of association of travel time to transplant center and posttransplant care model with outcome parameters after allogeneic transplantation.

Peter R; Halter JP; Heim D; Medinger M; Pabst T; Stussi G; Passweg JR; Gerull S. Bone marrow transplantation. 2021.

Legionellosis after hematopoietic stem cell transplantation

Mikulska M.; Tridello G.; Hoek J.; Gil L.; Yanez L.; Labussiere-Wallet H.; Passweg J.; Xhaard A.; Pioltelli P.; Caillot D.; Michel G.; Veelken H.; Blaise D.; Bruno B.; Garcia C.B.; Itala-Remes M.; Crawley C.; Bourhis J.H.; Kaare A.; Arcese W.; Parody R.; Styczynski J.. Bone marrow transplantation. 2021.

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.

Bejanyan N; Zhang M; Bo-Subait K; Brunstein C; Wang H; Warlick ED; Giralt S; Nishihori T; Martino R; Passweg J; Dias A; Copelan E; Hale G; Gale RP; Solh M; Kharfan-Dabaja MA; Diaz MA; Ganguly S; Gore S; Verdonck LF; Hossain NM; Kekre N; Savani B; Byrne M; Kanakry C; Cairo MS; Ciurea S; Schouten HC; Bredeson C; Munker R; Lazarus H; Cahn JY; van Der Poel M; Rizzieri D; Yared JA; Freytes C; Cerny J; Aljurf M; Palmisiano ND; Pawarode A; Bacher VU; Grunwald MR; Nathan S; Wirk B; Hildebrandt GC; Seo S; Olsson RF; George B; de Lima M; Hourigan CS; Sandmaier BM; Litzow M; Kebriaei P; Saber W; Weisdorf D. Transplantation and cellular therapy. 2021.

Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

Nabergoj M.; Mauff K.; Robin M.; Kroger N.; Angelucci E.; Poire X.; Passweg J.; Radujkovic A.; Platzbecker U.; Robinson S.; Rambaldi A.; Petersen S.L.; Stolzel F.; Stelljes M.; Ciceri F.; Mayer J.; Ladetto M.; de Wreede L.C.; Koster L.; Hayden P.J.; Czerw T.; Hernandez-Boluda J.C.; McLornan D.; Chalandon Y.; Yakoub-Agha I.. Bone marrow transplantation. 2021.

Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient's perspective?

Leuthold N; Cattaneo M; Halter J; Hügli C; Kirsch M; Petropoulou A; Erlanger TE; Gerull S; Passweg J; O'Meara Stern A. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021.

Possible Reactivation of SARS-CoV-2 in a Patient with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Case Report.

Dalla Via V; von Rotz M; Bättig V; Leuzinger K; Hirsch HH; Passweg J; Stüssi G; Medinger M. SN comprehensive clinical medicine. 2021.

Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation.

Arranto CA; Burkard T; Leuppi-Taegtmeyer AB; Gerull S; Passweg JR; Pfister O; Halter JP. Bone Marrow Transplantation. 2021.

Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Piñana JL; Xhaard A; Tridello G; Passweg J; Kozijn A; Polverelli N; Heras I; Perez A; Sanz J; Berghuis D; Vázquez L; Suárez-Lledó M; Itäla-Remes M; Ozcelik T; Iturrate Basarán I; Karakukcu M; Al Zahrani M; Choi G; Cuesta Casas MA; Batlle Massana M; Viviana A; Blijlevens N; Ganser A; Kuskonmaz B; Labussière-Wallet H; Shaw PJ; Yegin ZA; González-Vicent M; Rocha V; Ferster A; Knelange N; Navarro D; Mikulska M; de la Camara R; Styczynski J. The Journal of infectious diseases. 2021.

Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party

Hayden P.J.; Eikema D.-J.; de Wreede L.C.; Koster L.; Kroger N.; Einsele H.; Minnema M.; Dominietto A.; Potter M.; Passweg J.; Bermudez A.; Nguyen-quoc S.; Platzbecker U.; Tischer J.; Ciceri F.; Veelken J.H.; Ljungman P.; Schaap N.; Forcade E.; Carella A.M.; Gandemer V.; Arcese W.; Bloor A.; Olivieri A.; Vincent L.; Beksac M.; Schonland S.; Yakoub-Agha I.. Bone marrow transplantation. 2021.

Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Hirschbuhl K.; Labopin M.; Houhou M.; Gabellier L.; Labussiere-Wallet H.; Lioure B.; Beelen D.; Cornelissen J.; Wulf G.; Jindra P.; Tilly H.; Passweg J.; Niittyvuopio R.; Bug G.; Schmid C.; Nagler A.; Giebel S.; Mohty M.. Bone marrow transplantation. 2021.

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients

Rothschild S.I.; Nachbur R.; Herzog N.; Passweg J.R.; Pless M.. ESMO open. 2021.

Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT).

Iftikhar R; Ahmad P; de Latour R; Dufour C; Risitano A; Chaudhri N; Bazarbachi A; De La Fuente J; Höchsmann B; Osman Ahmed S; Gergis U; Elhaddad A; Halkes C; Albeirouti B; Alotaibi S; Kulasekararaj A; Alzahrani H; Ben Othman T; Cesaro S; Alahmari A; Rihani R; Alshemmari S; Hamidieh AA; Bekadja MA; Passweg J; Al-Khabori M; Rasheed W; Bacigalupo A; Chaudhry QU; Ljungman P; Marsh J; El Fakih R; Aljurf M; Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP of EBMT). Bone Marrow Transplantation. 2021.

The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).

Poiani M; Labopin M; Battipaglia G; Beelen DW; Tischer J; Finke J; Brecht A; Forcade E; Ganser A; Passweg JR; Labussiere-Wallet H; Yakoub-Agha I; Schäfer-Eckart K; Kroeger N; Guffroy B; Ruggeri A; Esteve J; Nagler A; Mohty M. American journal of hematology. 2021.

The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017.

Gay MHP; Baldomero H; Farge-Bancel D; Robey PG; Rodeo S; Passweg J; Müller-Gerbl M; Martin I. Tissue engineering. Part A. 2021.

Transfusions in Aplastic Anemia Patients Cause HLA Alloimmunization: Comparisons of Current and Past Cohorts Demonstrate Progress.

Julen K; Volken T; Holbro A; Infanti L; Halter JP; Schaub S; Wehmeier C; Diesch T; Rovó A; Passweg JR; Buser A; Drexler B. Transplantation and cellular therapy. 2021.

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

McLornan D.; Eikema D.J.; Czerw T.; Kroger N.; Koster L.; Reinhardt H.C.; Angelucci E.; Robin M.; Bornhauser M.; Passweg J.; Clark A.; Vydra J.; Blau I.E.; Niittyvuopio R.; Platzbecker U.; Cornelissen J.J.; Chevallier P.; Srour M.; Stamatovic D.; Martinez-Lopez J.; de Wreede L.; Hayden P.; Hernandez-Boluda J.C.; Yakoub-Agha I.. Bone marrow transplantation. 2021.

Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT.

Gagelmann N; Eikema DJ; de Wreede LC; Rambaldi A; Iacobelli S; Koster L; Caillot D; Blaise D; Remémyi P; Bulabois CE; Passweg J; Leleu X; Zver S; Kobbe G; Ljungman P; Chevallier P; Ringhoffer M; Martin M; Salmenniemi U; Poiré X; Lenhoff S; Pioltelli P; Mordini N; Delforge M; Garderet L; Schönland S; Yakoub-Agha I; Kröger N. Bone Marrow Transplantation. 2021.

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program

El Fakih R.; Greinix H.; Koh M.; Shaw B.; Mohty M.; Al Nahedh M.; Saber W.; Kharfan-Dabaja M.A.; Perales M.-A.; Savani B.N.; Majhail N.S.; Passweg J.R.; Sureda A.; Ahmed S.O.; Gluckman E.; Riches M.; El-Jawahri A.; Rondelli D.; Srivastava A.; Faulkner L.; Atsuta Y.; Ballen K.K.; Rasheed W.; Okamoto S.; Seber A.; Chao N.; Kroger N.; Kodera Y.; Szer J.; Hashmi S.K.; Horowitz M.M.; Weisdorf D.; Niederwieser D.; Aljurf M.. Transplantation and Cellular Therapy. 2021.

[Thrombocytopenia as an incidental finding].

Holbro A; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2020.

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis.

Bucher C; Halter J; Passweg J. . 2020.

Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.

Díaz-Beyá M; Labopin M; Maertens J; Aljurf M; Passweg J; Dietrich B; Schouten H; Socié G; Schaap N; Schwerdtfeger R; Volin L; Michallet M; Polge E; Sierra J; Mohty M; Esteve J; Nagler A; Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). British Journal of Haematology. 2020.

Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party.

Brissot E; Labopin M; Russo D; Martin S; Schmid C; Glass B; Ram R; Ozkurt ZN; Passweg J; Veelken JH; Bunjes D; Apperley J; Giebel S; Mohty M; Nagler A. Bone Marrow Transplantation. 2020.

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Miller PDE; Snowden JA; De Latour RP; Iacobelli S; Eikema DJ; Knol C; Marsh JCW; Rice C; Koh M; Fagioli F; Chaganti S; Finke J; Duarte RF; Bader P; Farge D; Passweg JR; Madrigal JA; Dufour C. Bone Marrow Transplantation. 2020.

Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Snowden J.A.; Saccardi R.; Orchard K.; Ljungman P.; Duarte R.F.; Labopin M.; McGrath E.; Brook N.; de Elvira C.R.; Gordon D.; Poirel H.A.; Ayuk F.; Beguin Y.; Bonifazi F.; Gratwohl A.; Milpied N.; Moore J.; Passweg J.; Rizzo J.D.; Spellman S.R.; Sierra J.; Solano C.; Sanchez-Guijo F.; Worel N.; Gusi A.; Adams G.; Balan T.; Baldomero H.; Macq G.; Marry E.; Mesnil F.; Oldani E.; Pearce R.; Perry J.; Raus N.; Schanz U.; Tran S.; Wilcox L.; Basak G.W.; Chabannon C.; Corbacioglu S.; Dolstra H.; Kuball J.; Mohty M.; Lankester A.; Montoto S.; Nagler A.; Styczynski J.; Yakoub-Agha I.; de Latour R.P.; Kroeger N.; Brand R.; de Wreede L.C.; van Zwet E.; Putter H.. Bone Marrow Transplantation. 2020.

Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP.

Hayden PJ; Iacobelli S; Pérez-Simón JA; van Biezen A; Minnema M; Niittyvuopio R; Schönland S; Meijer E; Blaise D; Milpied N; Márquez-Malaver FJ; Veelken JH; Maertens J; Michallet M; Cammenga J; N'Guyen S; Niederwieser D; Hunault-Berger M; Bourhis JH; Passweg J; Bermudez A; Chalandon Y; Yakoub-Agha I; Garderet L; Kröger N. European journal of haematology. 2020.

Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)

Snowden J.A.; Saccardi R.; Orchard K.; Ljungman P.; Duarte R.F.; Labopin M.; McGrath E.; Brook N.; de Elvira C.R.; Gordon D.; Poirel H.A.; Ayuk F.; Beguin Y.; Bonifazi F.; Gratwohl A.; Milpied N.; Moore J.; Passweg J.; Rizzo J.D.; Spellman S.R.; Sierra J.; Solano C.; Sanchez-Guijo F.; Worel N.; Gusi A.; Adams G.; Balan T.; Baldomero H.; Macq G.; Marry E.; Mesnil F.; Oldani E.; Pearce R.; Perry J.; Raus N.; Schanz U.; Tran S.; Wilcox L.; Basak G.W.; Chabannon C.; Corbacioglu S.; Dolstra H.; Kuball J.; Mohty M.; Lankester A.; Montoto S.; Nagler A.; Styczynski J.; Yakoub-Agha I.; de Latour R.P.; Kroeger N.; Brand R.; de Wreede L.C.; van Zwet E.; Putter H.. Bone Marrow Transplantation. 2020.

Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Buhler S; Baldomero H; Ferrari-Lacraz S; Nunes JM; Sanchez-Mazas A; Massouridi-Levrat S; Heim D; Halter J; Nair G; Chalandon Y; Schanz U; Güngör T; Nicoloso G; Tiercy JM; Passweg J; Villard J. . 2020.

Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH).

Weisshaar K; Ewald H; Halter J; Gerull S; Schönfeld S; Senft Y; Martinez M; Leuppi-Taegtmeyer A; Khanna N; Maier B; Risitano A; Peffault de Latour R; Tichelli A; Passweg J; Drexler B. Orphanet Journal of Rare Diseases. 2020.

Does the order of mutational acquisition in myeloproliferative neoplasms matter? Evidence from JAK2 exon 12 and DNMT3A co-mutant polycythemia vera

Todorova R.; Passweg J.; Lundberg P.; Tzankov A.. J Hematop. 2020.

First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study

Tschopp J.; L'Huillier A.G.; Mombelli M.; Mueller N.J.; Khanna N.; Garzoni C.; Meloni D.; Papadimitriou-Olivgeris M.; Neofytos D.; Hirsch H.H.; Schuurmans M.; Muller T.; Berney T.; Steiger J.; Pascual M.; Manuel O.; Van Delden C.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Hauri D.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Laube G.; Lehmann R.; Lovis C.; Majno P.; Manuel O.; Marti H.-P.; Martin P.Y.; Martinelli M.; Meylan P.; Mueller N.J.; Muller A.; Muller T.; Mullhaupt B.; Pascual M.; Passweg J.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Schuurmans M.; Seiler C.; Sprachta J.; Stampf S.; Steinack C.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020.

Guideline-based indicators for adult patients with myelodysplastic syndromes.

Stojkov K; Silzle T; Stussi G; Schwappach D; Bernhard J; Bowen D; Čermák J; Dinmohamed AG; Eeltink C; Eggmann S; Fenaux P; Germing U; Haschke M; Hellstrom-Lindberg E; Heger M; van de Loosdrecht AA; Passweg J; Pfeilstöcker M; Platzbecker U; Malcovati L; de Almeida AM; Mittelman M; Morgenthaler C; Steensma DP; Santini V; Stauder R; Symeonidis A; Schär S; Maddox C; de Witte T; Bohlius J; Bonadies N. Blood advances. 2020.

Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation.

Heilig CE; Badoglio M; Labopin M; Fröhling S; Secondino S; Heinz J; Nicolas-Virelizier E; Blaise D; Korenbaum C; Santoro A; Verbeek M; Krüger W; Siena S; Passweg JR; Di Nicola M; Rifón J; Dreger P; Koehl U; Chabannon C; Pedrazzoli P. ESMO open. 2020.

Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT).

ElGohary G; El Fakih R; de Latour R; Risitano A; Marsh J; Schrezenmeier H; Gluckman E; Höchsmann B; Pierri F; Halkes C; Alzahrani H; De la Fuente J; Cesaro S; Alahmari A; Ahmed SO; Passweg J; Dufour C; Bacigalupo A; Aljurf M. Bone Marrow Transplantation. 2020.

Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies.

Ehmann MA; Medinger M; Bodenmann B; Kraft S; Bollinger N; Heim D; Lengerke C; Tsakiris DA; Passweg J; Tzankov A; Menter T. . 2020.

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia.

Michallet M; Dreger P; Sobh M; Koster L; Hoek J; Boumendil A; Scheid C; Fox CP; Wulf G; Krüger W; van Gelder M; Corradini P; Russo D; Passweg J; Schoemans H; Bethge W; Schaap N; Cornelissen J; Browne P; Durakovic N; Muller L; Montoto S; Kroger N; Schetelig J; French Cooperative Group for CLL, SFGM-TC, and the EBMT Chronic Malignancy and Lymphoma Working Parties. Bone Marrow Transplantation. 2020.

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.

Sellner L; Schetelig J; Koster L; Choi G; Blaise D; Beelen D; Schianca FC; Passweg J; Schanz U; Gyan E; Sora F; Kröger N; Wulf GG; Van Gorkom G; Mayer J; Orvain C; Bourhis JH; Jindra P; Potter V; Zallio F; Vandenberghe E; Robinson S; Hayden PJ; Yakoub-Agha I; Montoto S; Dreger P; on behalf of the European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties. . 2020.

Incidence of CMV replication and the role of letermovir primary/secondary prophylaxis in the early phase after allogeneic hematopoietic stem cell transplantation ⇓ a single centre study

Studer U.; Khanna N.; Leuzinger K.; Hirsch H.H.; Heim D.; Lengerke C.; Tsakiris D.A.; Halter J.; Gerull S.; Passweg J.; Medinger M.; Gwerder M.. Anticancer research. 2020.

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia.

Schmaelter AK; Labopin M; Socié G; Itälä-Remes M; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Ganser A; Beelen D; Labussière-Wallet H; Passweg J; Savani BN; Schmid C; Nagler A; Mohty M. Blood Cancer Journal. 2020.

Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.

Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C; SAA Working Party of the EBMT. Haematologica. 2020.

Management of allergy transfer upon solid organ transplantation

Muller Y.D.; Vionnet J.; Beyeler F.; Eigenmann P.; Caubet J.-C.; Villard J.; Berney T.; Scherer K.; Spertini F.; Fricker M.P.; Lang C.; Schmid-Grendelmeier P.; Benden C.; Roux Lombard P.; Aubert V.; Immer F.; Pascual M.; Harr T.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Gasche Soccal P.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Hauri D.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Laube G.; Lehmann R.; Lovis C.; Majno P.; Manuel O.; Marti H.-P.; Yves Martin P.; Martinelli M.; Meylan P.; Morel P.; Mueller N.J.; Muller A.; Muller T.; Mullhaupt B.; Pascual M.; Passweg J.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Sprachta J.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020.

Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study

Vu D.-L.; Dayer J.-A.; Masouridi-Levrat S.; Combescure C.; Boely E.; Khanna N.; Mueller N.J.; Kleber M.; Medinger M.; Halter J.O.E.R.G.; Passweg J.; Muller A.M.; Schanz U.; Chalandon Y.; Neofytos D.; van Delden C.; Kaiser L.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Branca S.; Bucher H.; Carell T.; Catana E.; Geest S.; Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Manuel O.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller T.; Mullhaupt B.; Pascual M.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schaub S.; Schnyder A.; Seiler C.; Sprachta J.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant infectious disease : an official journal of the Transplantation Society. 2020.

MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages.

Nienhold R; Ashcroft P; Zmajkovic J; Rai S; Rao TN; Drexler B; Meyer SC; Lundberg P; Passweg JR; Leković D; Čokić V; Bonhoeffer S; Skoda RC. Blood. 2020.

New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.

Dalla Via V; Halter JP; Gerull S; Arranto C; Tichelli A; Heim D; Passweg JR; Medinger M; Cesana-Nigro N. In vivo (Athens, Greece). 2020.

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients.

Olearo F; Kronig I; Masouridi-Levrat S; Chalandon Y; Khanna N; Passweg J; Medinger M; Mueller NJ; Schanz U; Van Delden C; Neofytos D. Open forum infectious diseases. 2020.

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT.

McLornan DP; Malpassuti V; Lippinkhof-Kozijn A; Potter V; Beelen D; Bunjes D; Sengeloev H; Radujkovic A; Passweg J; Chalandon Y; Kröger N; Wulf GG; Johansson JE; Ciceri F; Bornhäuser M; Holler E; Guffroy B; Martin S; Neubauer A; Gramatski M; Robin M; Iacobelli S; Hayden P; Hernández Boluda JC; Czerw T; Yakoub-Agha I. British Journal of Haematology. 2020.

Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy.

Karakioulaki M; Martinez M; Medinger M; Heim D; Passweg JR; Tsakiris DA. International journal of laboratory hematology. 2020.

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Passweg JR; Labopin M; Christopeit M; Cornelissen J; Pabst T; Socié G; Russel N; Yakoub-Agha I; Blaise D; Gedde-Dahl T; Labussière-Wallet H; Malladi R; Forcade E; Maury S; Polge E; Lanza F; Gorin NC; Mohty M; Nagler A. Biology of Blood and Marrow Transplantation. 2020.

Pretransplant Genetic Susceptibility: Clinical Relevance in Transplant-Associated Thrombotic Microangiopathy.

Gavriilaki E; Touloumenidou T; Sakellari I; Batsis I; Mallouri D; Psomopoulos F; Tsagiopoulou M; Koutra M; Yannaki E; Papalexandri A; Taylor P; Nikolousis E; Stamouli M; Holbro A; Baltadakis I; Liga M; Spyridonidis A; Tsirigotis P; Charchalakis N; Tsakiris DA; Brodsky RA; Passweg J; Stamatopoulos K; Anagnostopoulos A. Thrombosis and haemostasis. 2020.

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.

Penack O; Marchetti M; Ruutu T; Aljurf M; Bacigalupo A; Bonifazi F; Ciceri F; Cornelissen J; Malladi R; Duarte RF; Giebel S; Greinix H; Holler E; Lawitschka A; Mielke S; Mohty M; Arat M; Nagler A; Passweg J; Schoemans H; Socié G; Solano C; Vrhovac R; Zeiser R; Kröger N; Basak GW. . 2020.

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Benz R; Arn K; Andres M; Pabst T; Baumann M; Novak U; Hitz F; Hess U; Zenhaeusern R; Chalandon Y; Mey U; Blum S; Rauch D; O'Meara Stern A; Cantoni N; Bargetzi M; Bianchi-Papina E; Rossi D; Passweg J; Lohri A; Berardi S; Li Q; Feller A; Stussi G. Blood advances. 2020.

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.

Bonifazi F; Rubio MT; Bacigalupo A; Boelens JJ; Finke J; Greinix H; Mohty M; Nagler A; Passweg J; Rambaldi A; Socie G; Solano C; Walker I; Barosi G; Kröger N. Bone Marrow Transplantation. 2020.

Relapse of Aplastic Anemia with Majority Donor Chimerism (Donor-Type Aplasia) Occurring Late after Bone Marrow Transplantation.

Shaw A; Passweg JR; De La Fuente J; Bajwa R; Stein J; Al-Zaben A; Halkes CJM; Norton A; Cummins M; Moppett JP; Shanap MA; Steward CG; Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 2020.

Respiratory viral infections prior to and after allogeneic haematopoietic cell transplantation.

Passweg JR; Khanna N; Halter J. British Journal of Haematology. 2020.

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study

Petersdorf E.W.; Carrington M.; O'hUigin C.; Bengtsson M.; De Santis D.; Dubois V.; Gooley T.; Horowitz M.; Hsu K.; Madrigal J.A.; Maiers M.J.; Malkki M.; McKallor C.; Morishima Y.; Oudshoorn M.; Spellman S.R.; Villard J.; Stevenson P.; Maiers M.; Spellman S.; Apperley J.; Bardy P.; Bernard G.; Bertrand Y.; Bloor A.; Bonini C.; Buhler S.; Bungener L.; Campbell H.; Carlson K.; Carpenter B.; Cesbron A.; Chabannon C.; Chalandon Y.; Chapman J.; Chebel R.; Chevallier P.; Choi G.; Collin M.; Cornelissen J.J.; Crawley C.; D'Orsogna L.; Dalle J.-H.; Deconinck E.; DeMatteis M.; Diviney M.; Dormoy A.; Gagne K.; Gibson B.; Gilleece M.; Gottlieb D.; Gribben J.; Gungor T.; Haagenson M.; Hart C.; Holdsworth R.; Humphreys I.; Kodera Y.; Koh M.; Labussiere-Wallet H.; Lankester A.C.; Lardy N.; Lawson S.; Leleu X.; MacKinnon S.; Malladi R.; Marsh S.G.; Martin M.; Mayor N.P.; McQuaker I.G.; Meijer E.; Morishima S.; Nikolousis E.; Orchard K.; Passweg J.; Patel A.; Patrick K.; Pedron B.; Peniket A.; Perry J.; Petersen E.; Potter V.; Potter M.; Protheroe R.; Raus N.; Ruiz de Elvira C.; Russell N.; Schaap N.P.; Schanz U.; Schouten H.; Skinner R.; Snowden J.; Spierings E.; Steward C.; Tholouli E.; Thornton A.; Tilanus M.; van de Meer A.; Veelkens H.; Veys P.; Watson N.; Weston L.; Wilson K.; Wilson M.; Wynn R.; Zsiros J.. Lancet Haematology. 2020.

Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes.

Schmied L; Olofsen PA; Lundberg P; Tzankov A; Kleber M; Halter J; Uhr M; Valk PJM; Touw IP; Passweg J; Drexler B. Blood advances. 2020.

Tear Proteomic Predictive Biomarker Model for Ocular Graft Versus Host Disease Classification.

O'Leary OE; Schoetzau A; Amruthalingam L; Geber-Hollbach N; Plattner K; Jenoe P; Schmidt A; Ullmer C; Drawnel FM; Fauser S; Scholl HPN; Passweg J; Halter JP; Goldblum D. Translational Vision Science & Technology. 2020.

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.

Passweg JR; Baldomero H; Chabannon C; Basak GW; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Peffault de Latour R; Snowden JA; Styczynski J; Yakoub-Agha I; Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2020.

The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.

Cowan AJ; Baldomero H; Atsuta Y; Mikhael J; Aljurf M; Seber A; Greinix H; Koh M; Worel N; Libby EN; Pasquini M; Galeano S; Saber W; Iida M; Jaimovich G; Rolon JM; Kodera Y; Benakli M; Nosa BG; Elhaddad A; Szer J; Passweg J; Kroeger N; Weisdorf D; Niederwieser D. Biology of Blood and Marrow Transplantation. 2020.

Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: The SMILe implementation science project

Ribaut J.; Leppla L.; Teynor A.; Valenta S.; Dobbels F.; Zullig L.L.; De Geest S.; Beckmann S.; Mielke J.; Schmid A.; Duerinckx N.; Heidegger P.; Furmann M.; Neupert D.; Rockstein D.; Werlitz V.; Furmann M.; Schulz T.; Lemcke M.; Schumacher V.; Zeiser R.; Engelhardt M.; Hasemann M.; Kaier K.; Gerull S.; Passweg J.; Ulrich A.; Grossmann F.; Bolliger D.; Reitwiessner S.; Degen S.; Schonfeld S.; Senft Y.; Maier B.; Shultis C.. BMC HEALTH SERVICES RESEARCH. 2020.

Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation.

Drexler B; Zurbriggen F; Diesch T; Viollier R; Halter JP; Heim D; Holbro A; Infanti L; Buser A; Gerull S; Medinger M; Tichelli A; Passweg JR. Annals of hematology. 2020.

[Acute lymphoblastic leukemia - diagnosis and therapy].

Medinger M; Heim D; Lengerke C; Halter JP; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2019.

[Bone marrow failure].

Drexler B; Tichelli A; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2019.

[Cellular therapies].

Holbro A; Heim D; Tschan-Plessl A; Baur K; Halter JP; Buser A; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2019.

[Diagnosis and Therapy of Acute Myeloid Leukemia].

Medinger M; Heim D; Halter JP; Lengerke C; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2019.

[Hematopoietic cell transplantation - essentials on indication, patient referral and long term follow up].

Halter JP; Gerull S; Arranto C; Medinger M; Heim D; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2019.

Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C. Nature. 2019.

Allogeneic stem cell transplantation for acquired pure red cell aplasia.

Halkes C; de Wreede LC; Knol C; Simand C; Aljurf M; Tbakhi A; Vazquez L; Bloor A; Wagner-Drouet E; Vural F; Bodova I; Isaksson C; Diaz MÁ; Gruhn B; Snowden J; Arat M; Bazarbachi A; Spilleboudt C; Kulagin A; Marsh JC; Passweg J; Risitano AM; Peffault de Latour R; Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party. . 2019.

Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.

Radujkovic A; Dietrich S; Blok HJ; Nagler A; Ayuk F; Finke J; Tischer J; Mayer J; Koc Y; Sorà F; Passweg J; Byrne JL; Jindra P; Veelken JH; Socié G; Maertens J; Schaap N; Stadler M; Itälä-Remes M; Tholouli E; Arat M; Rocha V; Ljungman P; Yakoub-Agha I; Kröger N; Chalandon Y. Biology of Blood and Marrow Transplantation. 2019.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis.

Robin M; Chevret S; Koster L; Wolschke C; Yakoub-Agha I; Bourhis JH; Chevallier P; Cornelissen JJ; Reményi P; Maertens J; Poiré X; Craddock C; Socié G; Itälä-Remes M; Schouten HC; Marchand T; Passweg J; Blaise D; Damaj G; Ozkurt ZN; Zuckerman T; Cluzeau T; Labussière-Wallet H; Cammenga J; McLornan D; Chalandon Y; Kröger N. Haematologica. 2019.

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.

Rovó A; Kulasekararaj A; Medinger M; Chevallier P; Ribera JM; Peffault de Latour R; Knol C; Iacobelli S; Kanfer E; Bruno B; Maury S; Quarello P; Koh MBC; Schouten H; Blau IW; Tichelli A; Hill A; Risitano A; Passweg J; Marsh J; Dreger P; Dufour C; Severe Aplastic Anaemia Working Party of the EBMT. British Journal of Haematology. 2019.

Autologous hematopoetic cell transplantation: preferred consolidation treatment in low-risk AML?

Passweg JR. Leukemia & lymphoma. 2019.

Baseline calprotectin fails to predict incidence of acute gastrointestinal graft vs. host disease: a prospective study.

Schmidlin N; Passweg JR; Halter JP; Heim D; Infanti L; Stern A; Plattner A; Plattner R; Medinger M; Kleber M; Rothen C; Buser A; Bucher C; Holbro A. Bone Marrow Transplantation. 2019.

Biological markers of hemostasis and endothelial activation in patients with a hematological malignancy with or without stem cell transplants.

Buser TA; Martinez M; Drexler B; Tschan-Plessl A; Heim D; Passweg J; Tsakiris DA. European journal of haematology. 2019.

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.

Moiseev IS; Tsvetkova T; Aljurf M; Alnounou RM; Bogardt J; Chalandon Y; Drokov MY; Dvirnyk V; Faraci M; Friis LS; Giglio F; Greinix HT; Kornblit BT; Koelper C; Koenecke C; Lewandowski K; Niederwieser D; Passweg JR; Peczynski C; Penack O; Peric Z; Piekarska A; Ronchi PE; Rovo A; Rzepecki P; Scuderi F; Sigrist D; Siitonen SM; Stoelzel F; Sulek K; Tsakiris DA; Wilkowojska U; Duarte RF; Ruutu T; Basak GW. Bone Marrow Transplantation. 2019.

Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.

Infanti L; Holbro A; Passweg J; Bolliger D; Tsakiris DA; Merki R; Plattner A; Tappe D; Irsch J; Lin JS; Corash L; Benjamin RJ; Buser A. Transfusion. 2019.

Common oral diseases, hyposalivation and survival post-HSCT, a longitudinal study.

Uutela P; Passweg J; Halter J; Gerull S; Weiger R; Mauramo E; Waltimo T; Mauramo M. European journal of haematology. 2019.

Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT.

Uutela P; Passweg J; Halter J; Weiger R; Waltimo T; Mauramo M. European journal of haematology. 2019.

Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Bianchi M; Heim D; Lengerke C; Halter J; Gerull S; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M. Annals of hematology. 2019.

Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation.

Mauramo M; Grolimund P; Egli A; Passweg J; Halter J; Waltimo T. PLoS One. 2019.

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.

Raj K; Eikema DJ; McLornan DP; Olavarria E; Blok HJ; Bregante S; Ciceri F; Passweg J; Ljungman P; Schaap N; Carlson K; Zuckerman T; de Wreede LC; Volin L; Koc Y; Diez-Martin JL; Brossart P; Wolf D; Blaise D; Bartolomeo PD; Vitek A; Robin M; Yakoub-Agha I; Chalandon Y; Kroger N. Biology of Blood and Marrow Transplantation. 2019.

High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.

Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M. Bone Marrow Transplantation. 2019.

High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Buhler S; Baldomero H; Ferrari-Lacraz S; Nunes JM; Sanchez-Mazas A; Massouridi-Levrat S; Heim D; Halter J; Nair G; Chalandon Y; Schanz U; Güngör T; Nicoloso G; Tiercy JM; Passweg J; Villard J. Bone Marrow Transplantation. 2019.

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.

Dreger P; Michallet M; Bosman P; Dietrich S; Sobh M; Boumendil A; Nagler A; Scheid C; Cornelissen J; Niederwieser D; Müller L; Vandenberghe E; Scortechini I; Schoemans H; Andersen NS; Finke J; Russo D; Ljungman P; Passweg J; van Gelder M; Durakovic N; Labussiere-Wallet H; Berg T; Wulf G; Bethge W; Bunjes D; Stilgenbauer S; Canepari ME; Schaap M; Fox CP; Kröger N; Montoto S; Schetelig J. Bone Marrow Transplantation. 2019.

Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT.

Giebel S; Labopin M; Czerw T; Socié G; Blaise D; Ghavamzadeh A; Passweg J; Ljungman P; Poiré X; Chevallier P; Reményi P; Rambaldi A; Anafasyev B; Fegueux N; Rovira M; Itälä-Remes M; Bornhäuser M; Mohty M; Nagler A. European journal of cancer (Oxford, England : 1990). 2019.

Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients.

Gerull S; Tschan-Plessl A; Mathew R; Nair G; Passweg JR; Halter JP. Bone Marrow Transplantation. 2019.

Leukämien 2020: Ein Update.

Passweg JR. . 2019.

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.

Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M. Journal of hematology & oncology. 2019.

Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.

Ghilardi G; Pabst T; Jeker B; Müller R; Cairoli A; Müller AMS; Bargetzi M; Hitz F; Baldomero H; Heim D; Schmidt A; Rossi D; Ghielmini M; Wannesson L; Lerch E; Samaras P; Schanz U; Passweg JR; Stussi G; Kleber M; Gerber B; Swiss Blood Stem Cell Transplantation Registry. Bone Marrow Transplantation. 2019.

Myelodysplastic syndromes Myelodysplastische Syndrome

Stehle G.; Schwarb H.; Passweg J.R.. Therapeutische Umschau. Revue therapeutique. 2019.

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.

Baldomero H; Aljurf M; Zaidi SZA; Hashmi SK; Ghavamzadeh A; Elhaddad A; Hamladji RM; Ahmed P; Torjemane L; Abboud M; Tbakhi A; Khabori MA; El Quessar A; Bazuaye N; Bekadja MA; Adil S; Fahmy O; Ramzi M; Ibrahim A; Alseraihy A; Ben Abdejalil N; Sarhan M; Huneini MA; Mahmal L; ElSolh H; Hussain F; Nassar A; Al-Hashmi H; Hamidieh AA; Pasquini M; Kodera Y; Kröger N; Mohty M; Jaimovich G; Rolon JM; Paulson K; Greinix H; Weisdorf D; Horowitz M; Nunez J; Gratwohl A; Passweg J; Koh M; Szer J; Niederwieser D; Novitzky N; East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplantation. 2019.

Obstacles to Widening Biosample Research.

Colledge F; Passweg J; Elger B. Science and engineering ethics. 2019.

Oral problems in patients undergoing haematology or oncology treatment

Ramseier A.M.; Passweg J.; Waltimo T.. . 2019.

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation.

Battipaglia G; Labopin M; Kröger N; Vitek A; Afanasyev B; Hilgendorf I; Schetelig J; Ganser A; Blaise D; Itälä-Remes M; Passweg JR; Bonifazi F; Finke J; Ruggeri A; Nagler A; Mohty M. Blood. 2019.

Predictors of impaired bone health in long-term survivors after allogeneic stem cell transplantation.

Baumgartner A; Moesch M; Zumsteg M; Struja T; Bernet S; Medinger M; Mueller B; Passweg J; Bargetzi M; Schuetz P. Bone Marrow Transplantation. 2019.

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT.

Styczynski J; Tridello G; Gil L; Ljungman P; Mikulska M; Ward KN; Cordonnier C; de la Camara R; Averbuch D; Knelange N; Socié G; Chevallier P; Blaise D; Yakoub-Agha I; Forcade E; Cornelissen J; Maertens J; Petersen E; Nguyen-Quoc S; Veelken H; Schaap N; Passweg J; Michallet M; Fegueux N; Deconinck E; Russell N; Basak G; Bader P; Montoto S; Kröger N; Cesaro S; Infectious Diseases Working Party EBMT. Bone Marrow Transplantation. 2019.

Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion.

Paczulla AM; Rothfelder K; Raffel S; Konantz M; Steinbacher J; Wang H; Tandler C; Mbarga M; Schaefer T; Falcone M; Nievergall E; Dörfel D; Hanns P; Passweg JR; Lutz C; Schwaller J; Zeiser R; Blazar BR; Caligiuri MA; Dirnhofer S; Lundberg P; Kanz L; Quintanilla-Martinez L; Steinle A; Trumpp A; Salih HR; Lengerke C. . 2019.

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.

Soltermann Y; Heim D; Medinger M; Baldomero H; Halter JP; Gerull S; Arranto C; Passweg JR; Kleber M. Annals of hematology. 2019.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.

Bazarbachi A; Labopin M; Battipaglia G; Djabali A; Passweg J; Socié G; Forcade E; Blaise D; Chevallier P; Orvain C; Cornelissen JJ; Arcese W; Chantepie S; Hashaishi K; El Cheikh J; Medinger M; Esteve J; Nagler A; Mohty M. . 2019.

Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Gagelmann N; Eikema DJ; Koster L; Caillot D; Pioltelli P; Lleonart JB; Reményi P; Blaise D; Schaap N; Trneny M; Passweg J; Porras RP; Cahn JY; Musso M; Poiré X; Fenk R; Itälä-Remes M; Pavone V; Fouillard L; Maertens J; Bron D; Pouli A; Schroyens W; Schönland S; Garderet L; Yakoub-Agha I; Kröger N. Biology of Blood and Marrow Transplantation. 2019.

Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.

Stivala S; Codilupi T; Brkic S; Baerenwaldt A; Ghosh N; Hao-Shen H; Dirnhofer S; Dettmer MS; Simillion C; Kaufmann BA; Chiu S; Keller M; Kleppe M; Hilpert M; Buser AS; Passweg JR; Radimerski T; Skoda RC; Levine RL; Meyer SC. The Journal of clinical investigation. 2019.

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Passweg JR; Baldomero H; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Kuball J; Lankester A; Montoto S; de Latour RP; Snowden JA; Styczynski J; Yakoub-Agha I; Arat M; Mohty M; Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2019.

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT.

Schmidt-Hieber M; Tridello G; Ljungman P; Mikulska M; Knelange N; Blaise D; Socié G; Volin L; Blijlevens N; Fegueux N; Yakoub-Agha I; Forcade E; Maertens J; Chevallier P; Passweg J; Cornelissen J; Russell N; Craddock C; Bourhis JH; Marchand T; Reményi P; Cahn JY; Michallet M; Montoto S; Kröger N; Glaß B; Styczynski J. . 2019.

The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14.

Drexler B; Passweg JR; Tzankov A; Bigler M; Theocharides AP; Cantoni N; Keller P; Stussi G; Ruefer A; Benz R; Favre G; Lundberg P; Nienhold R; Fuhrer A; Biaggi C; Manz MG; Bargetzi M; Mendez-Ferrer S; Skoda RC; Swiss Group for Clinical Cancer Research (SAKK). Haematologica. 2019.

The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.

Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A. Transfusion. 2019.

Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation.

Ortega Sanchez G; Stenner F; Dirnhofer S; Passweg J; Gerull S; Halter JP; Zippelius A; Läubli H. Swiss medical weekly. 2019.

Use of eltrombopag in aplastic anemia in Europe.

Ecsedi M; Lengline É; Knol-Bout C; Bosman P; Eikema DJ; Afanasyev B; Maschan A; Dreger P; Halkes CJM; Drexler B; Cortelezzi A; Drénou B; Patriarca A; Bruno B; Onofrillo D; Lanino E; Pulanic D; Serventi-Seiwerth R; Garnier A; Ljungman P; Bonifazi F; Giammarco S; Tournilhac O; Pioltelli P; Rovó A; Risitano AM; de Latour RP; Dufour C; Passweg J; EBMT SAA Working Party. Annals of hematology. 2019.

Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study

Schreiber P.W.; Bischoff-Ferrari H.A.; Boggian K.; van Delden C.; Enriquez N.; Fehr T.; Garzoni C.; Hirsch H.H.; Hirzel C.; Manuel O.; Meylan P.; Saleh L.; Weisser M.; Mueller N.J.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Ferrari-Lacraz S.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Marti H.-P.; Martin P.Y.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Pascual M.; Passweg J.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Sprachta J.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant International. 2019.

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Poiré X; Labopin M; Polge E; Passweg J; Craddock C; Blaise D; Cornelissen JJ; Volin L; Russell NH; Socié G; Michallet M; Fegueux N; Chevallier P; Brecht A; Hunault-Berger M; Mohty M; Esteve J; Nagler A. Haematologica. 2018.

Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.

Christopeit M; Labopin M; Gorin NC; Saraceni F; Passweg J; Forcade E; Maertens J; Van Lint MT; Bosi A; Niederwieser D; Ehninger G; Polge E; Mohty M; Nagler A. American journal of hematology. 2018.

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion.

Garderet L; Ziagkos D; van Biezen A; Iacobelli S; Finke J; Maertens J; Volin L; Ljungman P; Chevallier P; Passweg J; Schaap N; Beelen D; Nagler A; Blaise D; Poiré X; Yakoub-Agha I; Lenhoff S; Craddock C; Schots R; Rambaldi A; Sanz J; Jindra P; Mufti GJ; Robin M; Kröger N. Biology of Blood and Marrow Transplantation. 2018.

Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.

Czerw T; Labopin M; Giebel S; Socié G; Volin L; Fegueux N; Masszi T; Blaise D; Chaganti S; Cornelissen JJ; Passweg J; Maertens J; Itälä-Remes M; Wu D; Mohty M; Nagler A. Cancer. 2018.

Clostridium difficile infection is associated with graft loss in solid organ transplant recipients

Cusini A.; Beguelin C.; Stampf S.; Boggian K.; Garzoni C.; Koller M.; Manuel O.; Meylan P.; Mueller N.J.; Hirsch H.H.; Weisser M.; Berger C.; van Delden C.; Achermann R.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Binet I.; Bochud P.-Y.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Gasche Soccal P.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Martin P.Y.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2018.

Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.

Spahr Y; Tschudin-Sutter S; Baettig V; Compagno F; Tamm M; Halter J; Gerull S; Passweg J; Hirsch HH; Khanna N. Open forum infectious diseases. 2018.

Comparable outcomes of haploidentical, 10/10 and 9/10 unrelated donor transplantation in adverse karyotype AML in first complete remission.

Lorentino F; Labopin M; Bernardi M; Ciceri F; Socié G; Cornelissen JJ; Esteve J; Ruggeri A; Volin L; Yacoub-Agha I; Craddock C; Passweg J; Blaise D; Gedde-Dahl T; Poiani M; Fegueux N; Mohty M; Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology. 2018.

Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation.

Czyz A; Labopin M; Giebel S; Socié G; Apperley J; Volin L; Reményi P; Yakoub-Agha I; Orchard K; Michallet M; Stuhler G; Chaganti S; Murray M; Aljurf M; Bloor A; Passweg J; Finke J; Mohty M; Nagler A. American journal of hematology. 2018.

Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.

Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D. Transplant infectious disease : an official journal of the Transplantation Society. 2018.

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Craddock C; Versluis J; Labopin M; Socie G; Huynh A; Deconinck E; Volin L; Milpied N; Bourhis JH; Rambaldi A; Chevallier P; Blaise D; Manz M; Vellenga E; Vekemans MC; Maertens J; Passweg J; Vyas P; Schmid C; Löwenberg B; Ossenkoppele G; Mohty M; Cornelissen JJ; Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK. Journal of internal medicine. 2018.

Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data.

Premstaller M; Perren M; Koçack K; Arranto C; Favre G; Lohri A; Gerull S; Passweg JR; Halter JP; Leuppi-Taegtmeyer AB. Journal of Clinical Lipidology. 2018.

Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study

Neofytos D.; Chatzis O.; Nasioudis D.; Boely Janke E.; Doco Lecompte T.; Garzoni C.; Berger C.; Cussini A.; Boggian K.; Khanna N.; Manuel O.; Mueller N.J.; van Delden C.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Gasche Soccal P.; Gasche Soccal P.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Pascual M.; Passweg J.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Sprachta J.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant infectious disease : an official journal of the Transplantation Society. 2018.

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC.

Malard F; Labopin M; Cho C; Blaise D; Papadopoulos EB; Passweg J; O'Reilly R; Forcade E; Maloy M; Volin L; Castro-Malaspina H; Hicheri Y; Jakubowski AA; Orvain C; Giralt S; Mohty M; Nagler A; Perales MA. Journal of hematology & oncology. 2018.

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.

Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst. Swiss medical weekly. 2018.

Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation.

Holbro A; Baldomero H; Lanza F; Chabannon C; Snowden JA; Buser A; Infanti L; Worel N; Sureda A; Badoglio M; Passweg J; Bonini C; Cellular Therapy & Immunobiology Working Party of the European Society for Blood & Marrow Transplantation (EBMT) and the Joint Accreditation Committee International Society for Cellular Therapy & EBMT (JACIE).. Cytotherapy. 2018.

Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.

Schnegg-Kaufmann A; Feller A; Baldomero H; Rovo A; Manz MG; Gregor M; Efthymiou A; Bargetzi M; Hess U; Spertini O; Chalandon Y; Passweg JR; Stussi G; Arndt V; Bonadies N; NICER Working Group.. Cancer epidemiology. 2018.

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.

Cesaro S; Tridello G; Blijlevens N; Ljungman P; Craddock C; Michallet M; Martin A; Snowden JA; Mohty M; Maertens J; Passweg J; Petersen E; Nihtinen A; Isaksson C; Milpied N; Rohlich PS; Deconinck E; Crawley C; Ledoux MP; Hoek J; Nagler A; Styczynski J. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018.

Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study

Kuster S.; Stampf S.; Gerber B.; Baettig V.; Weisser M.; Gerull S.; Medinger M.; Passweg J.; Schanz U.; Garzoni C.; Berger C.; Chalandon Y.; Mueller N.J.; van Delden C.; Neofytos D.; Khanna N.; Achermann R.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Binet I.; Bochud P.-Y.; Bucher H.; Carell T.; Catana E.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Soccal G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Manuel O.; Marti H.-P.; Martin Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schaub S.; Schnyder A.; Seiler C.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant infectious disease : an official journal of the Transplantation Society. 2018.

Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.

Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D. Chest. 2018.

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.

Passweg JR; Baldomero H; Bader P; Basak GW; Bonini C; Duarte R; Dufour C; Kröger N; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2018.

Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM. The New England journal of medicine. 2018.

New-onset obesity after liver transplantation—outcomes and risk factors: the Swiss Transplant Cohort Study

Beckmann S.; Denhaerynck K.; Stampf S.; Saigi-Morgui N.; Binet I.; Koller M.; Boely E.; De Geest S.; Helmy R.; Leppla L.; Luta X.; Mauthner O.; Struker M.; Boehler A.; Gerull S.; Berben L.; Huynh-Do U.; Catana E.; Seiler A.; Klaghofer R.; Kunzler-Heule P.; Burkhalter H.; Achermann R.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Bochud P.-Y.; Bucher H.; Carell T.; Chalandon Y.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Immer F.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Manuel O.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller N.J.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant International. 2018.

Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation.

Schmid C; de Wreede LC; van Biezen A; Finke J; Ehninger G; Ganser A; Volin L; Niederwieser D; Beelen D; Alessandrino P; Kanz L; Schleuning M; Passweg J; Veelken H; Maertens J; Cornelissen JJ; Blaise D; Gramatzki M; Milpied N; Yakoub-Agha I; Mufti G; Rovira M; Arnold R; de Witte T; Robin M; Kröger N. Haematologica. 2018.

Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment.

Medinger M; Drexler B; Lengerke C; Passweg J. Frontiers in oncology. 2018.

Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort

Neofytos D.; Hirzel C.; Boely E.; Lecompte T.; Khanna N.; Mueller N.J.; Boggian K.; Cusini A.; Manuel O.; van Delden C.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Majno P.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Pascual M.; Passweg J.; Posfay-Barbe K.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Sprachta J.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Transplant infectious disease : an official journal of the Transplantation Society. 2018.

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.

Ciurea SO; Labopin M; Socie G; Volin L; Passweg J; Chevallier P; Beelen D; Milpied N; Blaise D; Cornelissen JJ; Fegueux N; Polge E; Kongtim P; Rondon G; Esteve J; Mohty M; Savani BN; Champlin RE; Nagler A. Cancer. 2018.

Severe anemia after trans-catheter arterial chemoembolization-an unusual presentation of hemoglobin Zurich.

Böhme T; Medinger M; Suenderhauf C; Speer O; Schmugge M; Passweg J; Bachofner A. Annals of hematology. 2018.

The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015

Ireland H.; Gay M.H.P.; Baldomero H.; De Angelis B.; Baharvand H.; Lowdell M.W.; Passweg J.; Martin I.. Cytotherapy. 2018.

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.

Saraceni F; Beohou E; Labopin M; Arcese W; Bonifazi F; Stepensky P; Aljurf M; Bruno B; Pioltelli P; Passweg J; Sociè G; Santarone S; Yakoub-Agha I; Lanza F; Savani BN; Mohty M; Nagler A; Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). American journal of hematology. 2018.

Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?

Giammarco S; Peffault de Latour R; Sica S; Dufour C; Socie G; Passweg J; Kröger N; Petersen E; Van Lint MT; Oneto R; Signori A; Bacigalupo A; European Group for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party. Blood. 2018.

What the internist should know about stem cell transplant in the elderly patient.

Medinger M; Passweg J. European journal of internal medicine. 2018.

Acquired Overlap Bone Marrow Failure Disorders

Passweg J.R.. . 2017.

Acute myeloid leukaemia genomics.

Medinger M; Passweg JR. British Journal of Haematology. 2017.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.

Robin M; Porcher R; Zinke-Cerwenka W; van Biezen A; Volin L; Mufti G; Craddock C; Finke J; Richard C; Passweg J; Peniket A; Maertens J; Sucak G; Gedde-Dahl T; Vitek A; Nagler A; Blaise D; Beelen D; Maillard N; Schwerdtfeger R; de Witte T; Kroger N. Bone Marrow Transplantation. 2017.

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.

de Witte T; Bowen D; Robin M; Malcovati L; Niederwieser D; Yakoub-Agha I; Mufti GJ; Fenaux P; Sanz G; Martino R; Alessandrino EP; Onida F; Symeonidis A; Passweg J; Kobbe G; Ganser A; Platzbecker U; Finke J; van Gelder M; van de Loosdrecht AA; Ljungman P; Stauder R; Volin L; Deeg HJ; Cutler C; Saber W; Champlin R; Giralt S; Anasetti C; Kröger N. Blood. 2017.

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

Versluis J; Labopin M; Ruggeri A; Socie G; Wu D; Volin L; Blaise D; Milpied N; Craddock C; Yakoub-Agha I; Maertens J; Ljungman P; Huynh A; Michallet M; Deconinck E; Chevallier P; Passweg J; Ciceri F; Mohty M; Cornelissen JJ; Nagler A. Blood advances. 2017.

Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Meyer SC; Steinmann E; Lehmann T; Muesser P; Passweg JR; Skoda RC; Tsakiris DA. BioMed research international. 2017.

Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.

van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J; CLL Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Clinical lymphoma, myeloma & leukemia. 2017.

BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study

Leboeuf C.; Wilk S.; Achermann R.; Binet I.; Golshayan D.; Hadaya K.; Hirzel C.; Hoffmann M.; Huynh-Do U.; Koller M.T.; Manuel O.; Mueller N.J.; Mueller T.F.; Schaub S.; van Delden C.; Weissbach F.H.; Hirsch H.H.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Bochud P.-Y.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hofbauer G.; Immer F.; Klaghofer R.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schnyder A.; Seiler C.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017.

Cardiac autonomic functioning is impaired among allogeneic hematopoietic stem cell transplantation survivors: a controlled study.

Deuring G; Kiss A; Halter JP; Passweg JR; Grossman P. Bone Marrow Transplantation. 2017.

Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT).

Schetelig J; de Wreede LC; Andersen NS; Moreno C; van Gelder M; Vitek A; Karas M; Michallet M; Machaczka M; Gramatzki M; Beelen D; Finke J; Delgado J; Volin L; Passweg J; Dreger P; Schaap N; Wagner E; Henseler A; van Biezen A; Bornhäuser M; Iacobelli S; Putter H; Schönland SO; Kröger N; CLL subcommittee, Chronic Malignancies Working Party. British Journal of Haematology. 2017.

Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML).

Fridle C; Medinger M; Wilk MC; Seipel K; Passweg J; Manz MG; Pabst T. Leukemia & lymphoma. 2017.

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.

Versluis J; In 't Hout FE; Devillier R; van Putten WL; Manz MG; Vekemans MC; Legdeur MC; Passweg JR; Maertens J; Kuball J; Biemond BJ; Valk PJ; van der Reijden BA; Meloni G; Schouten HC; Vellenga E; Pabst T; Willemze R; Löwenberg B; Ossenkoppele G; Baron F; Huls G; Cornelissen JJ. Leukemia. 2017.

Employment 12 months after kidney transplantation: An in-depth bio-psycho-social analysis of the Swiss Transplant Cohort

Danuser B.; Simcox A.; Studer R.; Koller M.; Wild P.; Lut B.; Hanna B.; Veerle C.; Sabina D.G.; Kris D.; Remon H.; Monika K.; Lynn L.; Oliver M.; Marian S.; Annette B.; Sabine G.; Michael K.; Uyen H.-D.; Elsa B.; Emmanuelle C.; Amira S.; Annina S.; Richard K.; Isabelle B.; Patrizia K.-H.; Sonja B.; Achermann R.; Amico P.; Aubert J.-D.; Baumann P.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; De Geest S.; De Rougemont O.; Dickenmann M.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Laesser B.; Lehmann R.; Lovis C.; Manuel O.; Marti H.-P.; Martin P.Y.; Martinolli L.; Meylan P.; Mohacsi P.; Morard I.; Morel P.; Mueller U.; Mueller N.J.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. PLoS One. 2017.

Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT (Bone Marrow Transplantation, (2017), 52, 2, (209-215), 10.1038/bmt.2016.266)

Robin M.; Porcher R.; Zinke-Cerwenka W.; van Biezen A.; Volin L.; Mufti G.; Craddock C.; Finke J.; Richard C.; Passweg J.; Peniket A.; Maertens J.; Sucak G.; Gedde-Dahl T.; Vitek A.; Nagler A.; Blaise D.; Beelen D.; Maillard N.; Schwerdtfeger R.; de Witte T.; Kroger N.. Bone marrow transplantation. 2017.

Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study

Beckmann S.; Nikolic N.; Denhaerynck K.; Binet I.; Koller M.; Boely E.; De Geest S.; Berben L.; Burkhalter H.; Claes V.; Helmy R.; Kirsch M.; Leppla L.; Mauthner O.; Struker M.; Boehler A.; Gerull S.; Huynh-Do U.; Catana E.; Simcox A.; Seiler A.; Klaghofer R.; Kunzler-Heule P.; Achermann R.; Amico P.; Aubert J.-D.; Banz V.; Beldi G.; Benden C.; Berger C.; Bochud P.-Y.; Bucher H.; Buhler L.; Carell T.; Chalandon Y.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Immer F.; Laesser B.; Lehmann R.; Lovis C.; Manuel O.; Marti H.-P.; Martin P.Y.; Meylan P.; Mohacsi P.; Morel P.; Mueller U.; Mueller N.J.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Clinical Transplantation. 2017.

ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial and health cost outcomeS (GERAS): protocol of a nationwide prospective cohort study

Mauthner O.; Claes V.; Walston J.; Engberg S.; Binet I.; Dickenmann M.; Golshayan D.; Hadaya K.; Huynh-Do U.; Calciolari S.; De Geest S.; Berben L.; Burkhalter H.; Denhaerynck K.; Helmy R.; Kirsch M.; Leppla L.; Struker M.; Boehler A.; Gerull S.; Koller M.; Boely E.; Catana E.; Simcox A.; Seiler A.; Klaghofer R.; Kunzler-Heule P.; Beckmann S.; Achermann R.; Amico P.; Aubert J.-D.; Baumann P.; Beldi G.; Benden C.; Berger C.; Bochud P.-Y.; Boely E.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; de Rougemont O.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Soccal P.G.; Giostra E.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Manuel O.; Marti H.-P.; Martin P.Y.; Martinolli L.; Meylan P.; Mohacsi P.; Morard I.; Morel P.; Mueller U.; Mueller N.J.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Pascual M.; Passweg J.; Ziegler C.P.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Journal of Advanced Nursing. 2017.

Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemia.

Kingston C; Medinger M; Banderet-Uglioni F; Bassetti S; Bargetzi M; Haubitz S; Fux CA; Bättig V; Goldenberger D; Passweg J; Heizmann M. Int J Infect Dis. 2017.

Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission.

Versluis J; Kalin B; Zeijlemaker W; Passweg J; Graux C; Manz MG; Vekemans MC; Biemond BJ; Legdeur MJC; Kooy MVM; de Weerdt O; Wijermans PW; Hoogendoorn M; Bargetzi MJ; Kuball J; Schouten HC; van der Velden VHJ; Janssen JJWM; Pabst T; Lowenberg B; Jongen-Lavrencic M; Schuurhuis GJ; Ossenkoppele G; Cornelissen JJ. JCO Precision Oncology. 2017.

GRAFT VERSUS LEUKEMIA EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION AND MINIMAL RESIDUAL DISEASE IN PATIENTS WITH AML IN FIRST COMPLETE REMISSION

Versluis, J.; Kalin, B.; Zeijlemaker, W.; Passweg, J.; Graux, C.; Manz, M.; Vekemans, M-C; Biemond, B.; Legdeur, M-C; Kooy, M. van Marwijk; Janssen, J.; Pabst, T.; Lowenberg, B.; Jongen-Lavrencic, M.; Schuurhuis, G. J.; Ossenkoppele, G.; Cornelissen, J.. Haematologica. 2017.

Haploidentical hematopoietic bone marrow transplantation followed by living kidney transplantation from the same donor in a sickle cell disease patient with end-stage renal failure.

Knüppel E; Medinger M; Stehle G; Infanti L; Halter J; Burkhalter F; Mujagic E; Heim D; Passweg J. Annals of hematology. 2017.

Human platelet antigen antibody induction in uncomplicated pregnancy is associated with HLA sensitization.

Reiher VSA; Hönger G; Infanti L; Passweg JR; Hösli I; Frey BM; Gassner C; Meyer S; Buser AS; Holbro A; Schaub S. Transfusion. 2017.

Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.

Medinger M; Zeiter D; Heim D; Halter J; Gerull S; Tichelli A; Passweg J; Nigro N. Leukemia research. 2017.

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT).

Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M. Bone Marrow Transplantation. 2017.

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation

Tichelli A.; Gerull S.; Holbro A.; Buser A.; Nair G.; Medinger M.; Heim D.; Halter J.P.; Passweg J.R.. Bone marrow transplantation. 2017.

Iron deficiency and thrombocytosis

Holbro A.; Volken T.; Buser A.; Sigle J.P.; Halter J.P.; Passweg J.R.; Tichelli A.; Infanti L.. Vox sanguinis. 2017.

Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study.

Gerull S; Denhaerynck K; Chalandon Y; Halter JP; Kirsch M; Kiss A; Schanz U; Vu DL; De Geest S; Passweg J. Bone Marrow Transplantation. 2017.

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.

Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C. Haematologica. 2017.

Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.

Pagliuca S; Peffault de Latour R; Volt F; Locatelli F; Zecca M; Dalle JH; Comoli P; Vettenranta K; Diaz MA; Reuven O; Bertrand Y; Diaz de Heredia C; Nagler A; Ghavamzadeh A; Sufliarska S; Lawson S; Kenzey C; Rocha V; Dufour C; Gluckman E; Passweg J; Ruggeri A. Biology of Blood and Marrow Transplantation. 2017.

Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.

Baumgartner A; Bargetzi M; Bargetzi A; Zueger N; Medinger M; Passweg J; Schanz U; Samaras P; Chalandon Y; Pichard C; Limonta A; Wannesson L; Pabst T; Duchosal MA; Hess U; Stanga Z; Mueller B; Schuetz P. Nutrition. 2017.

Overexpression of miR-21 involved in plasma cell myeloma-associated angiogenesis

Medinger, M.; Bollinger, N.; Bodenmann, B.; Kraft, S.; Heim, D.; Lengerke, C.; Passweg, J.. Oncology research and treatment. 2017.

Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study

Martin-Gandul C.; Stampf S.; Hequet D.; Mueller N.J.; Cusini A.; van Delden C.; Khanna N.; Boggian K.; Hirzel C.; Soccal P.; Hirsch H.H.; Pascual M.; Meylan P.; Manuel O.; Achermann R.; Amico P.; Aubert J.-D.; Baumann P.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; de Geest S.; de Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Yves Martin P.; Martinolli L.; Mohacsi P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Passweg J.; Piot Ziegler C.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Steiger J.; Stirnimann G.; Toso C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2017.

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.

Schetelig J; de Wreede LC; van Gelder M; Andersen NS; Moreno C; Vitek A; Karas M; Michallet M; Machaczka M; Gramatzki M; Beelen D; Finke J; Delgado J; Volin L; Passweg J; Dreger P; Henseler A; van Biezen A; Bornhäuser M; Schönland SO; Kröger N. Bone Marrow Transplantation. 2017.

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party.

Sobh M; Michallet M; Dubois V; Iacobelli S; Koster L; Van Biezen A; Fegueux N; Tabrizi R; Finke J; El-Cheikh J; Schipperus M; Meijer E; von dem Borne P; Petersen E; Russell N; Tholouli E; Passweg J; Garban F; Maertens J; Chevalier P; Maillard N; Volin L; Francois S; Lioure B; Beguin Y; Gluckman E; Ruggeri A; Garderet L; Kröger N. Haematologica. 2017.

Second-line Therapy Improves Overall Survival in Primary Refractory Non Small-Cell Lung Cancer (NSCLC) Patients

Rothschild, Sacha; Nachbur, Rebecca; Passweg, Jakob; Pless, Miklos. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017.

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.

Löwenberg B; Pabst T; Maertens J; van Norden Y; Biemond BJ; Schouten HC; Spertini O; Vellenga E; Graux C; Havelange V; de Greef GE; de Weerdt O; Legdeur MJ; Kuball J; Kooy MV; Gjertsen BT; Jongen-Lavrencic M; van de Loosdrecht AA; van Lammeren-Venema D; Hodossy B; Breems DA; Chalandon Y; Passweg J; Valk PJ; Manz MG; Ossenkoppele GJ; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Blood. 2017.

Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Eder S; Beohou E; Labopin M; Sanz J; Finke J; Arcese W; Or R; Bonifazi F; Aljurf M; Socié G; Passweg J; Giebel S; Mohty M; Nagler A. American journal of hematology. 2017.

Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Eder S; Canaani J; Beohou E; Labopin M; Sanz J; Arcese W; Or R; Finke J; Cortelezzi A; Beelen D; Passweg J; Socié G; Gurman G; Aljurf M; Stelljes M; Giebel S; Mohty M; Nagler A. American journal of hematology. 2017.

TRANSPLANTATION IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA OVER THE AGE OF 40: MORTALITY HAS NOT BEEN REDUCED IN 2010-2015

Giammarco, S.; Simona, S.; Dufour, C.; de latour, R. Peffault; Socie, G.; Passweg, J.; Bacigalupo, A.. Haematologica. 2017.

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M. Bone Marrow Transplantation. 2017.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.

Scheid C; de Wreede L; van Biezen A; Koenecke C; Göhring G; Volin L; Maertens J; Finke J; Passweg J; Beelen D; Cornelissen JJ; Itälä-Remes M; Chevallier P; Russell N; Petersen E; Milpied N; Richard Espiga C; Peniket A; Sierra J; Mufti G; Crawley C; Veelken JH; Ljungman P; Cahn JY; Alessandrino EP; de Witte T; Robin M; Kröger N. Bone Marrow Transplantation. 2017.

Workload even affects hand hygiene in a highly trained and well-staffed setting: a prospective 365/7/24 observational study.

Scheithauer S; Batzer B; Dangel M; Passweg J; Widmer A. Journal of Hospital Infection. 2017.

Allogeneic hematopoietic stem cell transplantation (HSCT) with an unrelated donor as first-line therapy in patients with severe aplastic anemia (SAA)

Tichelli, A.; Passweg, J.. Oncology research and treatment. 2016.

Allogeneic stem cell transplantation for elderly patients with intermediate-risk cytogenetic acute myeloid leukemia and internal tandem duplication of FLT3; a study from the Acute Leukemia Working Party of the EBMT

Poire, X.; Labopin, M.; Passweg, J.; Craddock, C.; Blaise, D.; Cornelissen, J. J.; Volin, L.; Russel, N. H.; Soci, G.; Michallet, M.; Fegueux, N.; Chevallier, P.; Stuhler, G.; Ifrah, N.; Mohty, M.; Esteve, J.; Nagler, A.. Bone Marrow Transplantation. 2016.

Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation

Ecsedi M.; Schmohl J.; Zeiser R.; Drexler B.; Halter J.; Medinger M.; Duyster J.; Kanz L.; Passweg J.; Finke J.; Bethge W.; Lengerke C.. Annals of hematology. 2016.

Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.

Baumgartner A; Zueger N; Bargetzi A; Medinger M; Passweg JR; Stanga Z; Mueller B; Bargetzi M; Schuetz P. Annals of nutrition & metabolism. 2016.

Bilateral optic disc swelling, vitreous haemorrhage and Roths spots in chronic myeloid leukemia

Rothenbuehler S.P.; Palmowski-Wolfe A.M.; Passweg J.R.; Hollbach N.. Tumor Diagnostik und Therapie. 2016.

bleedHD: a Tool for Assessment of Bleeding and Graftversus-Host Disease in Hemato-oncological Patients

Egger, M.; Halter, J.; Infanti, L.; Plattner, A.; Schefer, S.; Angerer, L.; Kistler, J.; Passweg, J.; Buser, A.; Holbro, A.. Bone Marrow Transplantation. 2016.

Comment: Shall Killer Cell Immunoglobulin-Like Receptor Genotyping be Incorporated in Donor Search Algorithms?

Passweg J.R.; Kalberer C.P.. Biology of Blood and Marrow Transplantation. 2016.

Comparable survival for poor-risk cytogenetics AML in first complete remission after haploidentical donor or unrelated donor transplantation: a study from the ALWP of EBMT

Lorentino, F.; Bernardi, M.; Labopin, M.; Ciceri, F.; Esteve, J.; Volin, L.; Cornelissen, J. J.; Blaise, D.; Socie, G.; Maertens, J.; Passweg, J.; Huang, X. -J.; Nagler, A.; Mohty, M.. Bone Marrow Transplantation. 2016.

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research.

Potter VT; Iacobelli S; van Biezen A; Maertens J; Bourhis JH; Passweg JR; Yakhoub-Agha I; Tabrizi R; Bay JO; Chevallier P; Chalandon Y; Huynh A; Cahn JY; Ljungman P; Craddock C; Lenhoff S; Russell NH; Fegueux N; Socié G; Bruno B; Meijer E; Mufti GJ; de Witte T; Robin M; Kröger N. Biology of Blood and Marrow Transplantation. 2016.

Encouraging short and long term survival after allogeneic stem cell transplantation for AL amyloidosis; a non-interventional study of the Chronic Malignancy Working Party of the EBMT

Schoenland, S. O.; Hegenbart, U.; Iacobelli, S.; Hoek, J.; Passweg, J.; Bordessoule, D.; Bourhis, J. -H.; Schipperus, M.; deWitte, T.; Garderet, L.; Kroeger, N.. Bone Marrow Transplantation. 2016.

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.

Masouridi-Levrat S; Simonetta F; Beauverd Y; Tsopra O; Tirefort Y; Stephan C; Levrat E; Ansari M; Verholen F; Roosnek E; Passweg JR; Chalandon Y. Bone Marrow Transplantation. 2016.

Gene-expression profiling in patients with plasma cell myeloma treated with novel agents

Medinger M.; Halter J.; Heim D.; Buser A.; Gerull S.; Lengerke C.; Passweg J.. Cancer Genomics and Proteomics. 2016.

Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel Agents.

Medinger M; Halter J; Heim D; Buser A; Gerull S; Lengerke C; Passweg J. Cancer Genomics and Proteomics. 2016.

Graft storage and disposal policies in a large group of european centers: a survey by the cellular therapy and immunobiology working party (CTIWP) of the European Group For Blood And Marrow Transplantation (EBMT)

Holbro, A.; Baldomero, H.; Buser, A.; Chabannon, C.; Lanza, F.; Snowden, J.; Worel, N.; Sureda, A.; Badoglio, M.; Passweg, J.; Bonini, C.. Bone Marrow Transplantation. 2016.

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

Niederwieser D.; Baldomero H.; Szer J.; Gratwohl M.; Aljurf M.; Atsuta Y.; Bouzas L.F.; Confer D.; Greinix H.; Horowitz M.; Iida M.; Lipton J.; Mohty M.; Novitzky N.; Nunez J.; Passweg J.; Pasquini M.C.; Kodera Y.; Apperley J.; Seber A.; Gratwohl A.. Bone Marrow Transplantation. 2016.

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.

Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M. Bone Marrow Transplantation. 2016.

Identification of baseline characteristics that predict good outcome of alloSCT in young Cll patients - a retrospective analysis from the CMWP of EBMT

Van Gelder, M.; Ziagkos, D.; de Wreede, L.; van Biezen, A.; Dreger, P.; Gramatzki, M.; Stelljes, M.; Andersen, N. Smedegard; Schaap, M.; Vitek, A.; Beelen, D.; Volin, L.; Finke, J.; Passweg, J.; Ganser, A.; Machaczka, M.; Delgado, J.; Krueger, W.; Faber, E.; Socie, G.; Jindra, P.; Henseler, A.; Schoenland, S.; Kroeger, N.; Schetelig, J.. Bone Marrow Transplantation. 2016.

Immunohematologic complications after hematopoietic stem cell transplantation across major ABO-barriers: comparison of three different transfusion strategies

Infanti, L.; Eissa, D.; Passweg, J.; Holbro, A.; Buser, A.. Bone Marrow Transplantation. 2016.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT.

Cahu X; Labopin M; Giebel S; Aljurf M; Kyrcz-Krzemien S; Socié G; Eder M; Bonifazi F; Bunjes D; Vigouroux S; Michallet M; Stelljes M; Zuckerman T; Finke J; Passweg J; Yakoub-Agha I; Niederwieser D; Sucak G; Sengeløv H; Polge E; Nagler A; Esteve J; Mohty M; Acute Leukemia Working Party of EBMT. Bone Marrow Transplantation. 2016.

Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.

Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016.

Impact of drug development on the use of Stem Cell Transplantation A report by the activity survey of the European Society for Blood and Marrow Transplantation (EBMT)

Passweg, J.; Baldomero, H.; Bader, P.; Bonini, C.; Cesaro, S.; Dreger, P.; Duarte, R. F.; Dufour, C.; Bancel, D. Farge; Gennery, A.; Kroeger, N.; Lanza, F.; Nagler, A.; Sureda, A.; Mohty, M.. Bone Marrow Transplantation. 2016.

Impact of procedure related factors and center effects on outcome of CLL transplantations

Schetelig, J.; de Wreede, L.; van Gelder, M.; Andersen, N. S.; Moreno, C.; Vitek, A.; Karas, M.; Michallet, M.; Machaczka, M.; Gramatzki, M.; Beelen, D.; Finke, J.; Delgado, J.; Volin, L.; Passweg, J.; Dreger, P.; Henseler, A.; van Biezen, A.; Bornhaeuser, M.; Schoenland, S. O.; Kroeger, N.. Bone Marrow Transplantation. 2016.

Improved outcome after T-cell depleted allogeneic hematopoietic stem cell transplantation for myelofibrosis

Simonetta, F.; Casini, A.; Wilk, M.; Ecsedi, M.; Andres, M.; Gerull, S.; Masouridi-Levrat, S.; Beauverd, Y.; Mohty, B.; Bucher, C.; Stern, M.; Manz, M.; Nair, G.; Schanz, U.; Passweg, J.; Chalandon, Y.. Bone Marrow Transplantation. 2016.

Improving results of unrelated donor - HCT for adults with acute lymphoblastic leukemia in first complete remission: an analysis from Acute Leukemia Working Party of the EBMT

Giebel, S.; Labopin, M.; Soci, G.; Volin, L.; Michallet, M.; Arnold, R.; Ringden, O.; Tabrizi, R.; Passweg, J.; Yakoub-Agha, I.; Lenhoff, S.; Kanz, L.; Nagler, A.. Bone Marrow Transplantation. 2016.

Inability to return to work and need for work disability pension among long term survivors of HSCT

Tichelli, A.; Gerull, S.; Holbro, A.; Buser, A.; Halter, J.; Passweg, J.. Bone Marrow Transplantation. 2016.

Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Medinger M; Heim D; Gerull S; Halter J; Krenger W; Buser A; Lengerke C; Bucher C; Passweg J. Leukemia research. 2016.

Indications for allogeneic stem cell transplantation in patients with AML

Passweg, J.. Oncology research and treatment. 2016.

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.

Penack O; Tridello G; Hoek J; Socié G; Blaise D; Passweg J; Chevallier P; Craddock C; Milpied N; Veelken H; Maertens J; Ljungman P; Cornelissen J; Thiebaut-Bertrand A; Lioure B; Michallet M; Iacobelli S; Nagler A; Mohty M; Cesaro S. Bone Marrow Transplantation. 2016.

Longer observation times reveal long-latency leukemia induction from human AML cells engrafted into NSG mice

Paczulla, A.; Dimhofer, S.; Medinger, M.; Salih, H. R.; Rothfelder, K.; Passweg, J.; Tsakiris, D.; Lundberg, P.; Lengerke, C.. Oncology research and treatment. 2016.

Novel prognostic and therapeutic mutations in acute myeloid leukemia

Medinger M.; Lengerke C.; Passweg J.. Cancer Genomics and Proteomics. 2016.

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.

Medinger M; Lengerke C; Passweg J. Cancer Genomics and Proteomics. 2016.

Novel therapeutic options in Acute Myeloid Leukemia.

Medinger M; Lengerke C; Passweg J. Leukemia Research Reports. 2016.

Outcomes of allogeneic stem cell transplantation for acquired pure red cell aplasia. An ongoing analysis of the EBMT Severe Aplastic Anemia working party

Halkes, C.; de Wreede, L.; Knol-Bout, J.; Kulagin, A.; Risitano, A.; Marsh, J.; de la Tour, R. Peffault; Passweg, J.; Dufour, C.. Bone Marrow Transplantation. 2016.

Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation

Golshayan D.; Wojtowicz A.; Bibert S.; Pyndiah N.; Manuel O.; Binet I.; Buhler L.H.; Huynh-Do U.; Mueller T.; Steiger J.; Pascual M.; Meylan P.; Bochud P.-Y.; Achermann R.; Aubert J.-D.; Baumann P.; Beldi G.; Benden C.; Berger C.; Boely E.; Bucher H.; Carell T.; Catana E.; Chalandon Y.; De Geest S.; De Rougemont O.; Dickenmann M.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Garzoni C.; Gasche Y.; Soccal P.G.; Giostra E.; Good D.; Hadaya K.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Immer F.; Klaghofer R.; Koller M.; Kuntzen T.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Martin P.Y.; Mohacsi P.; Morard I.; Morel P.; Mueller U.; Mueller N.J.; Mueller-Mckenna H.; Muller T.; Mullhaupt B.; Nadal D.; Nair G.; Passweg J.; Piot Ziegler C.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Seiler C.; Semmo N.; Stampf S.; Toso C.; Tsinalis D.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Kidney International. 2016.

Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)

Kroeger, N.; Putter, H.; de Wreede, L.; van Biezen, A.; Ziagkos, D.; Volin, L.; Maertens, J.; Finke, J.; Ljungman, P.; Russell, N.; Yakoub-Agha, I.; Schaap, M.; Craddock, C.; Mufti, G.; Chevallier, P.; Passweg, J.; Milpied, N.; Blaise, D.; Bourhis, J. H.; Gedde-Dahl, T.; Espiga, C. R.; Cornelissen, J.; Goehring, G.; Schetelig, J.; de Witte, T.; Robin, M.. Bone Marrow Transplantation. 2016.

Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma: outcomes from 10/10 HLA-matched unrelated donors, 9/10 HLA-mismatched unrelated donors and cord blood. A study by the EBMT and Eurocord

Michallet, M.; Sobh, M.; Dubois, V.; Iacobelli, S.; Koster, L.; Van Biezen, A.; Ceballos, P.; Tabrizi, R.; Finke, J.; El-Cheikh, J.; Schipperus, M.; Meijer, E.; Veelken, J. H.; Petersen, E.; Russell, N.; Tholouli, E.; Passweg, J.; Garban, F.; Schoemans, H.; Chevalier, P.; Maillard, N.; Volin, L.; Francois, S.; Lioure, B.; Beguin, Y.; Gluckman, E.; Ruggeri, A.; Garderet, L.; Kroeger, N.. Bone Marrow Transplantation. 2016.

The hierarchy of alternative donors for allogeneic hematopoietic stem cell transplantation in poor risk Aml in CR1 revisited

Versluis, J.; Labopin, M.; Ruggeri, A.; Socie, G.; Wu, D.; Volin, L.; Blaise, D.; Milpied, N.; Craddock, C.; Yakoub-Agha, I.; Maertens, J.; Ljungman, P.; Huynh, A.; Michallet, M.; Deconinck, E.; Chevallier, P.; Passweg, J.; Ciceri, F.; Mohty, M.; Cornelissen, J.; Nagler, A.. Bone Marrow Transplantation. 2016.

The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013

Martin I.; Ireland H.; Baldomero H.; Dominici M.; Saris D.B.; Passweg J.. Tissue engineering. Part A. 2016.

Thiotepa-based conditioning for allogeneic stem cell transplantation (allo-HSCT) in acute lymphoblastic leukaemia (ALL) - a survey and matched-pair analysis from the ALWP of the EBMT

Eder, S.; Beohou, E.; Labopin, M.; Sanz, J.; Finke, J.; Arcese, W.; Or, R.; Bonifazi, F.; Aljurf, M.; Socie, G.; Passweg, J.; Giebel, S.; Mohty, M.; Nagler, A.. Bone Marrow Transplantation. 2016.

Unusual Association of Aplastic Anemia and Lymphoid Neoplasm: A Survey of the Severe Aplastic Anemia Working Party of the EBMT

Rovo, A.; Kulasekararaj, A.; Medinger, M.; Chevallier, P.; Ribera, J.; de Latour, R. Peffault; Knol, C.; Iacobelli, S.; Kanfer, E.; Benedetto, B.; Maury, S.; Quarello, P.; Koh, M.; Schouten, H.; Blau, I.; Tichelli, A.; Risitano, A.; Passweg, J.; Marsh, J.; Dreger, P.; Dufour, C.. Bone Marrow Transplantation. 2016.

Ventricular assist devices as bridge to heart transplantation: Impact on post-transplant infections

Hequet D.; Kralidis G.; Carrel T.; Cusini A.; Garzoni C.; Hullin R.; Meylan P.R.; Mohacsi P.; Mueller N.J.; Ruschitzka F.; Tozzi P.; Van Delden C.; Weisser M.; Wilhelm M.J.; Pascual M.; Manuel O.; Achermann R.; Amico P.; Aubert J.-D.; Baumann P.; Beldi G.; Benden C.; Berger C.; Binet I.; Bochud P.-Y.; Boely E.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; Geest S.; Rougemont O.; Dickenmann M.; Duchosal M.; Elkrief L.; Fehr T.; Ferrari-Lacraz S.; Soccal P.G.; Gaudet C.; Giostra E.; Golshayan D.; Hadaya K.; Halter J.; Heim D.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Martin P.Y.; Martinolli L.; Meylan P.; Morel P.; Mueller U.; Mueller-McKenna H.; Muller A.; Muller T.; Mullhaupt B.; Nadal D.; Passweg J.; Ziegler C.P.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Schanz U.; Schaub S.; Schnyder A.; Seiler C.; Stampf S.; Steiger J.; Stirnimann G.; Toso C.; Van Delden C.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. BMC INFECTIOUS DISEASES. 2016.

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

Halter J.P.; Michael W.; Schupbach M.; Mandel H.; Casali C.; Orchard K.; Collin M.; Valcarcel D.; Rovelli A.; Filosto M.; Dotti M.T.; Marotta G.; Pintos G.; Barba P.; Accarino A.; Ferra C.; Illa I.; Beguin Y.; Bakker J.A.; Boelens J.J.; De Coo I.F.M.; Fay K.; Sue C.M.; Nachbaur D.; Zoller H.; Sobreira C.; Pinto Simoes B.; Hammans S.R.; Savage D.; Marti R.; Chinnery P.F.; Elhasid R.; Gratwohl A.; Hirano M.; Barros Navarro G.; Benoist J.F.; Bierau J.; Bucalossi A.; Carluccio M.A.; Coll-Canti J.; Cotelli M.S.; Diesch T.; Di Fabio R.; Donati M.A.; Garvin J.H.; Hill K.; Kappeler L.; Ku Hne T.; Lara M.C.; Lenoci M.; Lucchini G.; Marques W.; Mattle H.P.; Meyer A.; Parini R.; Passweg J.R.; Pieroni F.; Rodriguez-Palmero A.; Santus F.; Scarpelli M.; Schlesser P.; Sicurelli F.; Stern M.; Stracieri A.B.; Tonin P.; Torres-Torronteras J.; Voltarelli J.C.; Zaidman I.. Brain : a journal of neurology. 2015.

A mindfulness-based program for improving quality of life among hematopoietic stem cell transplantation survivors: feasibility and preliminary findings.

Grossman P; Zwahlen D; Halter JP; Passweg JR; Steiner C; Kiss A. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2015.

Bilateral optic disc swelling, vitreous haemorrhage and roth's spots in chronic myeloid leukemia Bilaterale Papillenschwellung, Glaskörperblutung und Roth-Flecken bei chronisch myeloischer Leukämie

Rothenbuehler S.P.; Palmowski-Wolfe A.M.; Passweg J.R.; Hollbach N.. Klinische Monatsblatter fur Augenheilkunde. 2015.

Combination therapy for multidrug-resistant cytomegalovirus disease.

Stuehler C; Stüssi G; Halter J; Nowakowska J; Schibli A; Battegay M; Dirks J; Passweg J; Heim D; Rovo A; Kalberer C; Bucher C; Weisser M; Dumoulin A; Hirsch HH; Khanna N. Transplant infectious disease : an official journal of the Transplantation Society. 2015.

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years

Cornelissen J.J.; Versluis J.; Passweg J.R.; Van Putten W.L.J.; Manz M.G.; Maertens J.; Beverloo H.B.; Valk P.J.M.; Van Marwijk Kooy M.; Wijermans P.W.; Schaafsma M.R.; Biemond B.J.; Vekemans M.-C.; Breems D.A.; Verdonck L.F.; Fey M.F.; Jongen-Lavrencic M.; Janssen J.J.W.M.; Huls G.; Kuball J.; Pabst T.; Graux C.; Schouten H.C.; Gratwohl A.; Vellenga E.; Ossenkoppele G.; Lowenberg B.. Leukemia. 2015.

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.

Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NP; López-Corral L; Poire X; Passweg J; Hamljadi RM; Thomas SH; Schonland S; Gahrton G; Morris C; KrÖger N; Garderet L. Bone Marrow Transplantation. 2015.

Conditioning intensity in middle-aged patients with AML in first CR: No advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Passweg J.R.; Labopin M.; Cornelissen J.; Volin L.; Socie G.; Huynh A.; Tabrizi R.; Wu D.; Craddock C.; Schaap N.; Kuball J.; Chevallier P.; Cahn J.Y.; Blaise D.; Ghavamzadeh A.; Bilger K.; Ciceri F.; Schmid C.; Giebel S.; Nagler A.; Mohty M.. Bone marrow transplantation. 2015.

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.

Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC; Aplastic Anemia Working Party of the European Group for Blood Marrow Transplantation. Haematologica. 2015.

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.

Gratwohl A; Sureda A; Baldomero H; Gratwohl M; Dreger P; Kröger N; Ljungman P; McGrath E; Mohty M; Nagler A; Rambaldi A; de Elvira CR; Snowden JA; Passweg J; Apperley J; Niederwieser D; Stijnen T; Brand R; Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) and the European Leukemia Net (ELN). EBioMedicine. 2015.

Erythropoietin receptor mutation—a rush of blood to the head?

Holbro A.; Skoda R.; Lundberg P.; Passweg J.; Buser A.; Lehmann T.. Annals of hematology. 2015.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Falkenburg JH; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2015.

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.

Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM; Swiss Blood Stem Cell Transplantation Group. Bone Marrow Transplantation. 2015.

Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.

Stuehler C; Kuenzli E; Jaeger VK; Baettig V; Ferracin F; Rajacic Z; Kaiser D; Bernardini C; Forrer P; Weisser M; Elzi L; Battegay M; Halter J; Passweg J; Khanna N. The Journal of infectious diseases. 2015.

Impact of recipient ABH secretor status on outcome in minor ABO-incompatible hematopoietic stem cell transplantation

Holbro A.; Stern M.; Infanti L.; O'Meara A.; Drexler B.; Frey B.M.; Tiercy J.-M.; Passweg J.R.; Gassner C.; Buser A.; Sigle J.-P.. Transfusion. 2015.

Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.

Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N; MDS subcommittee of the Chronic Malignancies Working Party of the EBMT. Haematologica. 2015.

Influence of selective serotonin reuptake inhibitors on bleeding risk in patients with severe thrombocytopenia after chemotherapy: a retrospective study.

Schäfer C; O'Meara A; Tsakiris DA; Medinger M; Passweg JR; Stern M. Acta haematologica. 2015.

Is admission screening for Pseudomonas aeruginosa useful in haematologic patients? A prospective study with 1310 patients.

Sidler JA; Frei R; Tschudin-Sutter S; Dangel M; Battegay M; Weisser M; Passweg J; Widmer AF. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2015.

Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT.

Eggimann L; Girsberger S; Halter J; Gerull S; Tichelli A; Baldomero H; Heim D; Passweg J; Rovó A. Bone Marrow Transplantation. 2015.

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation.

Binkert L; Medinger M; Halter JP; Heim D; Gerull S; Holbro A; Lengerke C; Weisser M; Passweg JR. Bone Marrow Transplantation. 2015.

Management of hemolytic anemia following allogeneic stem cell transplantation.

Holbro A; Passweg JR. Hematology. American Society of Hematology. Education Program. 2015.

Multispecific aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections

Stuehler C.; Nowakowska J.; Bernardini C.; Topp M.S.; Battegay M.; Passweg J.; Khanna N.. The Journal of infectious diseases. 2015.

Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Matthes T; McKee T; Dunand-Sauthier I; Manfroi B; Park S; Passweg J; Huard B. Leukemia. 2015.

Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML

Medinger M.; Krenger W.; Jakab A.; Halter J.; Buser A.; Bucher C.; Passweg J.; Tzankov A.. Bone marrow transplantation. 2015.

One million haemopoietic stem-cell transplants: a retrospective observational study.

Gratwohl A; Pasquini MC; Aljurf M; Atsuta Y; Baldomero H; Foeken L; Gratwohl M; Bouzas LF; Confer D; Frauendorfer K; Gluckman E; Greinix H; Horowitz M; Iida M; Lipton J; Madrigal A; Mohty M; Noel L; Novitzky N; Nunez J; Oudshoorn M; Passweg J; van Rood J; Szer J; Blume K; Appelbaum FR; Kodera Y; Niederwieser D; Worldwide Network for Blood and Marrow Transplantation (WBMT). The Lancet. Haematology. 2015.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

Nagler A; Savani BN; Labopin M; Polge E; Passweg J; Finke J; Kyrcz-Krzemien S; Volin L; Anagnostopoulos A; Aljurf M; Beelen DW; Vigouroux S; Milpied N; Suarez F; Mohty M. The Lancet. Haematology. 2015.

Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: A time-dependent analysis

Versluis J.; Hazenberg C.L.E.; Passweg J.R.; Van Putten W.L.J.; Maertens J.; Biemond B.J.; Theobald M.; Graux C.; Kuball J.; Schouten H.C.; Pabst T.; Lowenberg B.; Ossenkoppele G.; Vellenga E.; Cornelissen J.J.; Meulendijks I.; Cornelisse P.; van Hooije C.; Biaggi C.; van der Holt B.; Labopin M.. Lancet Haematology. 2015.

Reply to Cunha et al

Wojtowicz A.; Lecompte T.D.; Bibert S.; Manuel O.; Rueger S.; Berger C.; Boggian K.; Cusini A.; Garzoni C.; Khanna N.; Mueller N.J.; Meylan P.R.; Pascual M.; Van Delden C.; Bochud P.-Y.; Aubert J.-D.; Beldi G.; Benden C.; Binet I.; Boely E.; Bucher H.; Buhler L.; Carell T.; Catana E.; Chalandon Y.; De Geest S.; De Rougemont O.; Dickenmann M.; Duchosal M.; Fehr T.; Ferrari-Lacraz S.; Gasche Y.; Soccal P.G.; Giostra E.; Golshayan D.; Good D.; Hadaya K.; Hess C.; Hillinger S.; Hirsch H.H.; Hofbauer G.; Huynh-Do U.; Immer F.; Klaghofer R.; Koller M.; Kuntzen T.; Laesser B.; Lehmann R.; Lovis C.; Marti H.-P.; Martin P.Y.; Mohacsi P.; Morard I.; Morel P.; Mueller U.; Mueller-Mckenna H.; Muller T.; Mullhaupt B.; Nadal D.; Nair G.; Passweg J.; Ziegler C.P.; Rick J.; Roosnek E.; Rosselet A.; Rothlin S.; Ruschitzka F.; Schanz U.; Schaub S.; Seiler C.; Semmo N.; Stampf S.; Steiger J.; Toso C.; Tsinalis D.; Venetz J.-P.; Villard J.; Wick M.; Wilhelm M.; Yerly P.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015.

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.

Zeiser R; Burchert A; Lengerke C; Verbeek M; Maas-Bauer K; Metzelder SK; Spoerl S; Ditschkowski M; Ecsedi M; Sockel K; Ayuk F; Ajib S; de Fontbrune FS; Na IK; Penter L; Holtick U; Wolf D; Schuler E; Meyer E; Apostolova P; Bertz H; Marks R; Lübbert M; Wäsch R; Scheid C; Stölzel F; Ordemann R; Bug G; Kobbe G; Negrin R; Brune M; Spyridonidis A; Schmitt-Gräff A; van der Velden W; Huls G; Mielke S; Grigoleit GU; Kuball J; Flynn R; Ihorst G; Du J; Blazar BR; Arnold R; Kröger N; Passweg J; Halter J; Socié G; Beelen D; Peschel C; Neubauer A; Finke J; Duyster J; von Bubnoff N. Leukemia. 2015.

Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.

Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S. British Journal of Haematology. 2015.

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

Tschan-Plessl A.; Halter J.P.; Heim D.; Medinger M.; Passweg J.R.; Gerull S.. Annals of hematology. 2015.

Temperature-Sensitive Indicators for Monitoring RBC Concentrates Out of Controlled Temperature Storage.

Sigle JP; Holbro A; Lehmann T; Infanti L; Gerull S; Stern M; Tichelli A; Passweg J; Buser A. American journal of clinical pathology. 2015.

The role of hematopoietic stem cell transplantation in chronic myeloid leukemia.

Gratwohl A; Baldomero H; Passweg J. Annals of hematology. 2015.

The survey on cellular and engineered tissue therapies in Europe in 2012.

Martin I; Ireland H; Baldomero H; Passweg J. Tissue engineering. Part A. 2015.

Travelling activity and travel-related risks after allogeneic haematopoietic stem cell transplantation - A single centre survey

Hollenstein Y.; Elzi L.; Hatz C.; Passweg J.; Weisser M.; Stockle M.; Halter J.P.; Egli A.. Swiss medical weekly. 2015.

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies.

Levrat E; Roosnek E; Masouridi S; Mohty B; Ansari M; Villard J; Passweg JR; Chalandon Y. Bone marrow research. 2015.

Angiogenesis in myeloproliferative neoplasms, new markers and future directions.

Medinger M; Passweg J. Memo - Magazine of European Medical Oncology. 2014.

A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking.

Manegold-Brauer G; Borner B; Bucher C; Hoesli I; Passweg J; Girsberger S; Schoetzau A; Gisin S; Visca E. Transfusion. 2014.

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).

Passweg JR; Pabst T; Blum S; Bargetzi M; Li Q; Heim D; Stussi G; Gregor M; Leoncini L; Meyer-Monard S; Brauchli P; Chalandon Y; Swiss Group for Clinical Cancer Research (SAKK). Leukemia & lymphoma. 2014.

Challenges and opportunities for HSCT outcome registries: Perspective from international HSCT registries experts

Aljurf M.; Rizzo J.D.; Mohty M.; Hussain F.; Madrigal A.; Pasquini M.C.; Passweg J.; Chaudhri N.; Ghavamzadeh A.; Solh H.E.; Atsuta Y.; Szer J.; Kodera Y.; Niederweiser D.; Gratwohl A.; Horowitz M.M.. Bone Marrow Transplantation. 2014.

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

Lundberg P; Karow A; Nienhold R; Looser R; Hao-Shen H; Nissen I; Girsberger S; Lehmann T; Passweg J; Stern M; Beisel C; Kralovics R; Skoda RC. Blood. 2014.

Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment.

Holbro A; Graf L; Topalidou M; Bucher C; Passweg JR; Tsakiris DA. Transfusion. 2014.

Dkk3 levels in patients with myeloproliferative neoplasms.

Medinger M; Muesser P; Girsberger S; Skoda R; Tzankov A; Buser A; Passweg J; Tsakiris DΑ. Thrombosis research. 2014.

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.

Chalandon Y; Passweg JR; Guglielmi C; Iacobelli S; Apperley J; Schaap NP; Finke J; Robin M; Fedele R; Bron D; Yakoub-Agha I; van Biezen A; de Witte T; Kröger N; Olavarria E; Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2014.

Evaluation of the pretransplantation workup before allogeneic transplantation.

Gerull S; Medinger M; Heim D; Passweg J; Stern M. Biology of Blood and Marrow Transplantation. 2014.

Forty years of haematopoietic stem cell transplantation: A review of the Basel experience

O'Meara A.; Holbro A.; Meyer S.; Martinez M.; Medinger M.; Buser A.; Halter J.; Heim D.; Gerull S.; Bucher C.; Rovo A.; Kuhne T.; Tichelli A.; Gratwohl A.; Stern M.; Passweg J.R.. Swiss medical weekly. 2014.

Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease

Affolter K.; Tamm M.; Jahn K.; Halter J.; Passweg J.; Hirsch H.H.; Stolz D.. American Journal of Respiratory and Critical Care Medicine. 2014.

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.

Passweg JR; Baldomero H; Peters C; Gaspar HB; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Farge-Bancel D; Gennery A; Halter J; Kröger N; Lanza F; Marsh J; Mohty M; Sureda A; Velardi A; Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Bone Marrow Transplantation. 2014.

Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy.

Brehm C; Huenecke S; Esser R; Kloess S; Quaiser A; Betz S; Zimmermann O; Soerensen J; Passweg JR; Klingebiel T; Schwabe D; Bader P; Koehl U. Cancer immunology, immunotherapy : CII. 2014.

Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.

Bürgler D; Medinger M; Passweg J; Fischmann A; Bucher C. Leukemia research. 2014.

Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma.

Rueff J; Medinger M; Heim D; Passweg J; Stern M. Biology of Blood and Marrow Transplantation. 2014.

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.

Avivi I; Canals C; Vernant JP; Wulf G; Nagler A; Hermine O; Petersen E; Yakoub-Agha I; Craddock C; Schattenberg A; Niederwieser D; Thomson K; Blaise D; Attal M; Pfreundschuh M; Passweg J; Russell N; Dreger P; Sureda A; EBMT Lymphoma Working Party. Bone Marrow Transplantation. 2014.

Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to Myelodysplastic Syndrome or Leukemia from Severe Aplastic Anemia: A Report from the MDS Subcommittee of the Chronic Malignancies Working Party and the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

Hussein, Ayad Ahmed; Halkes, Constantijn M.; Socie, Gerard; Tichelli, Andre; von dem Borne, Peter A.; Schaap, Michel N. P. M.; Foa, Robin; Ganser, Arnold; Dufour, Carlo; Bacigalupo, Andrea; Locasciulli, Anna; Aljurf, Mahmoud; Peters, Christina; Robin, Marie; van Biezen, Anja A.; Volin, Liisa; De Witte, Theo; Marsh, Judith; Passweg, Jakob R.; Kroeger, Nicolas. Biology of Blood and Marrow Transplantation. 2014.

Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.

Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J. Haematologica. 2014.

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

Ruutu T.; Gratwohl A.; De Witte T.; Afanasyev B.; Apperley J.; Bacigalupo A.; Dazzi F.; Dreger P.; Duarte R.; Finke J.; Garderet L.; Greinix H.; Holler E.; Kroger N.; Lawitschka A.; Mohty M.; Nagler A.; Passweg J.; Ringden O.; Socie G.; Sierra J.; Sureda A.; Wiktor-Jedrzejczak W.; Madrigal A.; Niederwieser D.. Bone Marrow Transplantation. 2014.

Role of tumour angiogenesis in haematological malignancies.

Medinger M; Passweg J. Swiss medical weekly. 2014.

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

Marek A.; Stern M.; Chalandon Y.; Ansari M.; Ozsahin H.; Gungor T.; Gerber B.; Kuhne T.; Passweg J.R.; Gratwohl A.; Tichelli A.; Seger R.; Schanz U.; Halter J.; Stussi G.. Bone Marrow Transplantation. 2014.

The survey on cellular and engineered tissue therapies in Europe in 2011.

Martin I; Baldomero H; Bocelli-Tyndall C; Emmert MY; Hoerstrup SP; Ireland H; Passweg J; Tyndall A. Tissue engineering. Part A. 2014.

Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.

Robin M; Giannotti F; Deconinck E; Mohty M; Michallet M; Sanz G; Chevallier P; Cahn JY; Legrand F; Rovira M; Passweg J; Sierra J; Nguyen S; Maillard N; Yakoub-Agha I; Linkesch W; Cannell P; Marcatti M; Bay JO; Chalandon Y; Kröger N; Gluckman E; Rocha V; Olavarria E; Ruggeri A; Eurocord and Chronic Malignancies Working Party-European Group for Blood and Marrow Transplantation (CMWP-EBMT). Biology of Blood and Marrow Transplantation. 2014.

Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis.

Vuichard D; Weisser M; Orasch C; Frei R; Heim D; Passweg JR; Widmer AF. BMC INFECTIOUS DISEASES. 2014.

Withdrawn: Matched sibling donor hematopoietic stem cell transplant in patients with acquired aplastic anemia.

. CURRENT DRUG TARGETS. 2014.

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013.

Allogeneic stem cell transplantation for relapsed or refractory lymphoma after conditioning with BEAM/fludarabine/TBI.

O'Meara A; Halter J; Heim D; Gerull S; Bucher C; Passweg J; Buser A; Stern M. Biology of Blood and Marrow Transplantation. 2013.

Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT.

Gerull S; Stern M; Ben Aissa A; Manz MG; Schanz U; Stussi G; Chalandon Y; Passweg J; Mohty B. Bone Marrow Transplantation. 2013.

Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.

Spahr L; Chalandon Y; Terraz S; Kindler V; Rubbia-Brandt L; Frossard JL; Breguet R; Lanthier N; Farina A; Passweg J; Becker CD; Hadengue A. PLoS One. 2013.

Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol

Koehl U.; Brehm C.; Huenecke S.; Zimmermann S.-Y.; Kloess S.; Bremm M.; Ullrich E.; Soerensen J.; Quaiser A.; Erben S.; Wunram C.; Gardlowski T.; Auth E.; Tonn T.; Seidl C.; Meyer-Monard S.; Stern M.; Passweg J.; Klingebiel T.; Bader P.; Schwabe D.; Esser R.. Frontiers in oncology. 2013.

Comparison of a powered bone marrow biopsy device with a manual system: results of a prospective randomised controlled trial.

Bucher CM; Lehmann T; Tichelli A; Tzankov A; Dirnhofer S; Passweg J; Rovó A. Journal of clinical pathology. 2013.

Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components

Sigle J.-P.; Infanti L.; Studt J.-D.; Martinez M.; Stern M.; Gratwohl A.; Passweg J.; Tichelli A.; Buser A.S.. Transfusion. 2013.

Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.

Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A. Biology of Blood and Marrow Transplantation. 2013.

GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM.

Medinger M; Tichelli A; Bucher C; Halter J; Dirnhofer S; Rovo A; Passweg J; Tzankov A. Bone Marrow Transplantation. 2013.

Haematopoietic stem cell transplantation: Activity in Switzerland compared with surrounding European countries

Passweg J.R.; Baldomero H.; Bargetzi M.; Bucher C.; Chalandon Y.; Duchosal M.A.; Gratwohl A.; Gungor T.; Hess U.; Leibundgut K.; De Faveri G.N.; Ozsahin H.; Pabst T.; Renner C.; Stern M.; Stussi G.; Schanz U.. Swiss medical weekly. 2013.

Hematopoietic SCT in Europe: data and trends in 2011.

Passweg JR; Baldomero H; Bregni M; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Kröger N; Farge-Bancel D; Gaspar HB; Marsh J; Mohty M; Peters C; Sureda A; Velardi A; Ruiz de Elvira C; Madrigal A; European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 2013.

Hematopoietic stem cell transplantation activity in Europe

Gratwohl, Alois; Baldomero, Helen; Passweg, Jakob. CURRENT OPINION IN HEMATOLOGY. 2013.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Terwijn M; van Putten WL; Kelder A; van der Velden VH; Brooimans RA; Pabst T; Maertens J; Boeckx N; de Greef GE; Valk PJ; Preijers FW; Huijgens PC; Dräger AM; Schanz U; Jongen-Lavrecic M; Biemond BJ; Passweg JR; van Gelder M; Wijermans P; Graux C; Bargetzi M; Legdeur MC; Kuball J; de Weerdt O; Chalandon Y; Hess U; Verdonck LF; Gratama JW; Oussoren YJ; Scholten WJ; Slomp J; Snel AN; Vekemans MC; Löwenberg B; Ossenkoppele GJ; Schuurhuis GJ. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013.

Immunological and autoimmune considerations of Autism Spectrum Disorders.

Gesundheit B; Rosenzweig JP; Naor D; Lerer B; Zachor DA; Procházka V; Melamed M; Kristt DA; Steinberg A; Shulman C; Hwang P; Koren G; Walfisch A; Passweg JR; Snowden JA; Tamouza R; Leboyer M; Farge-Bancel D; Ashwood P. Journal of autoimmunity. 2013.

Impact of selection of cord blood units from the United States and swiss registries on the cost of banking operations.

Bart T; Boo M; Balabanova S; Fischer Y; Nicoloso G; Foeken L; Oudshoorn M; Passweg J; Tichelli A; Kindler V; Kurtzberg J; Price T; Regan D; Shpall EJ; Schwabe R. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 2013.

Increase of suicide and accidental death after hematopoietic stem cell transplantation A Cohort Study on Behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Tichelli, Andre; Labopin, Myriam; Rovo, Alicia; Badoglio, Manuela; Arat, Mutlu; van Lint, Maria Teresa; Lawitschka, Anita; Schwarze, Carl Philipp; Passweg, Jakob; Socie, Gerard. Cancer. 2013.

Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation.

Lanza F; Campioni DC; Hellmann A; Milone G; Wahlin A; Walewski J; Spedini P; Fiamenghi C; Cuneo A; Knopińska W; Swierkowska-Czeneszew M; Petriz J; Fruehauf S; Farge D; Mohty M; Passweg J; Ruuto T; Madrigal A; Johnsen HE; Quality Assessment of Haematopoietic Stem Cell Grafting Committee of European Blood and Marrow Transplantation Society. Biology of Blood and Marrow Transplantation. 2013.

Is acute fibrinous and organizing pneumonia the expression of immune dysregulation?

Labarinas S; Gumy-Pause F; Rougemont AL; Baerlocher G; Leibundgut EO; Porret N; Schäppi MG; Barazzone-Argiroffo C; Passweg J; Merlini L; Ozsahin H; Ansari M. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2013.

JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.

Girsberger S; Karow A; Lundberg P; Dirnhofer S; Lehmann T; Passweg JR; Tichelli A; Skoda R; Rovó A. Acta haematologica. 2013.

Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Holbro,Andreas; Lehmann,Thomas; Girsberger,Sabine; Stern,Martin; Gambazzi,Franco; Lardinois,Didier; Heim,Dominik; Passweg,Jakob R; Tichelli,André; Bubendorf,Lukas; Savic,Spasenija; Hostettler,Katrin; Grendelmeier,Peter; Halter,Joerg P; Tamm,Michael. Biology of Blood and Marrow Transplantation. 2013.

Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Rovó A; Aljurf M; Chiodi S; Spinelli S; Salooja N; Sucak G; Hunter A; Kim TS; Socié G; van Lint MT; Passweg JR; Arat M; Badoglio M; Tichelli A; Late Effects Working Party of the EBMT. Haematologica. 2013.

Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia.

Maury S; Balère-Appert ML; Pollichieni S; Oneto R; Yakoub-Agha I; Locatelli F; Dalle JH; Lanino E; Fischer A; Pession A; Huynh A; Barberi W; Mohty M; Risitano A; Milpied N; Socié G; Bacigalupo A; Marsh J; Passweg JR; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). American journal of hematology. 2013.

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: A prospective phase II study in two centers

Stern M.; Passweg J.R.; Meyer-Monard S.; Esser R.; Tonn T.; Soerensen J.; Paulussen M.; Gratwohl A.; Klingebiel T.; Bader P.; Tichelli A.; Schwabe D.; Koehl U.. Bone Marrow Transplantation. 2013.

Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M. Biology of Blood and Marrow Transplantation. 2013.

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

Gratwohl A; Baldomero H; Gratwohl M; Aljurf M; Bouzas LF; Horowitz M; Kodera Y; Lipton J; Iida M; Pasquini MC; Passweg J; Szer J; Madrigal A; Frauendorfer K; Niederwieser D; Worldwide Network of Blood and Marrow Transplantation (WBMT). Haematologica. 2013.

Reply to: Towards a rational graft-versus-host disease prophylaxis: rituximab should not be forgotten.

Bucher CM; Passweg J. Haematologica. 2013.

Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.

Aljurf M; Al-Zahrani H; Van Lint MT; Passweg JR. Bone Marrow Transplantation. 2013.

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation

Gerull, Sabine; Stern, Martin; Apperley, Jane; Beelen, Dietrich; Brinch, Lorentz; Bunjes, Donald; Butler, Andrew; Ganser, Arnold; Ghavamzadeh, Ardeshir; Koh, Mickey B.; Komarnicki, Mieczyslaw; Kroeger, Nicolaus; Maertens, Johan; Maschan, Alexei; Peters, Christina; Rovira, Montserrat; Sengelov, Henrik; Socie, Gerard; Tischer, Johanna; Oneto, Rosi; Passweg, Jakob; Marsh, Judith. Haematologica. 2013.

The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.

Schlenk RF; Taskesen E; van Norden Y; Krauter J; Ganser A; Bullinger L; Gaidzik VI; Paschka P; Corbacioglu A; Göhring G; Kündgen A; Held G; Götze K; Vellenga E; Kuball J; Schanz U; Passweg J; Pabst T; Maertens J; Ossenkoppele GJ; Delwel R; Döhner H; Cornelissen JJ; Döhner K; Löwenberg B. Blood. 2013.

Treatment and hematopoietic SCT in aplastic anemia.

Passweg JR; Aljurf M. Bone Marrow Transplantation. 2013.

Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).

Ossenkoppele GJ; Stussi G; Maertens J; van Montfort K; Biemond BJ; Breems D; Ferrant A; Graux C; de Greef GE; Halkes CJ; Hoogendoorn M; Hollestein RM; Jongen-Lavrencic M; Levin MD; van de Loosdrecht AA; van Marwijk Kooij M; van Norden Y; Pabst T; Schouten HC; Vellenga E; Verhoef GE; de Weerdt O; Wijermans P; Passweg JR; Löwenberg B. Blood. 2012.

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Sureda, Anna; Canals, Carme; Arranz, Reyes; Caballero, Dolores; Ribera, Josep Maria; Brune, Mats; Passweg, Jacob; Martino, Rodrigo; Valcarcel, David; Besalduch, Joan; Duarte, Rafael; Leon, Angel; Jesus Pascual, Maria; Garcia-Noblejas, Ana; Lopez Corral, Lucia; Xicoy, Bianca; Sierra, Jordi; Schmitz, Norbert. Haematologica. 2012.

Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria

de Latour, Regis Peffault; Schrezenmeier, Hubert; Bacigalupo, Andrea; Blaise, Didier; de Souza, Carmino A.; Vigouroux, Stephane; Willemze, Roelf; Terriou, Louis; Tichelli, Andre; Mohty, Mohamad; de Guibert, Sophie; Marsh, Judith C.; Passweg, Jakob; Mary, Jean Yves; Socie, Gerard. Haematologica. 2012.

Aplastic anemia in association with a lymphoproliferative neoplasm: Coincidence or causality?

Medinger M.; Buser A.; Stern M.; Heim D.; Halter J.; Rovo A.; Tzankov A.; Tichelli A.; Passweg J.. Leukemia research. 2012.

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Bacigalupo A; Socié G; Schrezenmeier H; Tichelli A; Locasciulli A; Fuehrer M; Risitano AM; Dufour C; Passweg JR; Oneto R; Aljurf M; Flynn C; Mialou V; Hamladji RM; Marsh JC; Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT). Haematologica. 2012.

Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT.

Mohty B; Thomas Y; Vukicevic M; Nagy M; Levrat E; Bernimoulin M; Kaiser L; Roosnek E; Passweg J; Chalandon Y. Bone Marrow Transplantation. 2012.

Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.

Cornelissen JJ; Breems D; van Putten WL; Gratwohl AA; Passweg JR; Pabst T; Maertens J; Beverloo HB; van Marwijk Kooy M; Wijermans PW; Biemond BJ; Vellenga E; Verdonck LF; Ossenkoppele GJ; Löwenberg B. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012.

Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases.

Daikeler T; Tichelli A; Passweg J. Pediatric research. 2012.

Equal Efficacy of Glucoprotamin and an Aldehyde Product for Environmental Disinfection in a Hematologic Transplant Unit: A Prospective Crossover Trial

Meinke, Ruth; Meyer, Bernhard; Frei, Reno; Passweg, Jakob; Widmer, Andreas F.. Infection Control and Hospital Epidemiology. 2012.

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

Pabst T; Vellenga E; van Putten W; Schouten HC; Graux C; Vekemans MC; Biemond B; Sonneveld P; Passweg J; Verdonck L; Legdeur MC; Theobald M; Jacky E; Bargetzi M; Maertens J; Ossenkoppele GJ; Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German AML Study Group (AMLSG); Swiss Collaborative Group for Clinical Cancer Research (SAKK). Blood. 2012.

Future trends in hematopoietic stem cell transplantation.

Halter J; Passweg J; Häusermann P. Current problems in dermatology. 2012.

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

Snowden, J. A.; Saccardi, R.; Allez, M.; Ardizzone, S.; Arnold, R.; Cervera, R.; Denton, C.; Hawkey, C.; Labopin, M.; Mancardi, G.; Martin, R.; Moore, J. J.; Passweg, J.; Peters, C.; Rabusin, M.; Rovira, M.; van Laar, J. M.; Farge, D.. Bone Marrow Transplantation. 2012.

Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner.

Passweg JR; Halter J; Bucher C; Gerull S; Heim D; Rovó A; Buser A; Stern M; Tichelli A. Swiss medical weekly. 2012.

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

Battiwalla M; Wang T; Carreras J; Deeg HJ; Ayas M; Bajwa RP; George B; Gupta V; Pasquini R; Schrezenmeier H; Passweg JR; Schultz KR; Eapen M. Biology of Blood and Marrow Transplantation. 2012.

Initial cord blood unit volume affects mononuclear cell and CD34 <sup>+</sup> cell-processing efficiency in a non-linear fashion

Meyer-Monard S.; Tichelli A.; Troeger C.; Arber C.; De Faveri G.N.; Gratwohl A.; Roosnek E.; Surbek D.; Chalandon Y.; Irion O.; Castelli D.; Passweg J.; Kindler V.. Cytotherapy. 2012.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

Buchbinder D; Nugent DJ; Brazauskas R; Wang Z; Aljurf MD; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS. Biology of Blood and Marrow Transplantation. 2012.

Lung resection in hematologic patients with pulmonary invasive fungal disease.

Nebiker CA; Lardinois D; Junker L; Gambazzi F; Matt P; Habicht JM; Halter J; Heim D; Stern M; Buser AS; Passweg J; Stolz D; Flückiger UM; Weisser M; Battegay M; Bubendorf L; Gratwohl A; Tamm M. Chest. 2012.

Natural killer cell immunity after transplantation

Terszowski, Grzegorz; Passweg, Jakob R.; Stern, Martin. Swiss medical weekly. 2012.

Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.

Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012.

Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: A survey of centre strategies by the European Group for Blood and Marrow Transplantation

Ruutu T.; Van Biezen A.; Hertenstein B.; Henseler A.; Garderet L.; Passweg J.; Mohty M.; Sureda A.; Niederwieser D.; Gratwohl A.; De Witte T.. Bone Marrow Transplantation. 2012.

Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.

Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G; European Blood and Marrow Transplant Group Severe Aplastic Anaemia Working Party. Blood. 2012.

The EBMT activity survey: 1990-2010

Passweg J.R.; Baldomero H.; Gratwohl A.; Bregni M.; Cesaro S.; Dreger P.; Witte T.D.; Farge-Bancel D.; Gaspar B.; Marsh J.; Mohty M.; Peters C.; Tichelli A.; Velardi A.; De Elvira C.R.; Falkenburg F.; Sureda A.; Madrigal A.. Bone Marrow Transplantation. 2012.

The survey on cellular and engineered tissue therapies in Europe in 2010.

Martin I; Baldomero H; Bocelli-Tyndall C; Passweg J; Saris D; Tyndall A. Tissue engineering. Part A. 2012.

Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.

Ansari M; Strunk D; Schallmoser K; Delcò C; Rougemont AL; Moll S; Villard J; Gumy-Pause F; Chalandon Y; Parvex P; Passweg J; Ozsahin H; Kindler V. Pediatric transplantation. 2012.

Towards rational graft-versus-host disease prophylaxis.

Bucher CM; Passweg JR. Haematologica. 2012.

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

Tichelli A; Schrezenmeier H; Socié G; Marsh J; Bacigalupo A; Dührsen U; Franzke A; Hallek M; Thiel E; Wilhelm M; Höchsmann B; Barrois A; Champion K; Passweg JR. Blood. 2011.

A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.

Medinger M; Saller E; Harteveld CL; Lehmann T; Graf L; Rovo A; Buser A; Passweg J; Tichelli A. Hematology reports. 2011.

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal.

Fontanet A; Chalandon Y; Roosnek E; Mohty B; Passweg JR. Bone Marrow Transplantation. 2011.

Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?

Ansari M; Vukicevic M; Rougemont AL; Moll S; Parvex P; Gumy-Pause F; Chalandon Y; Passweg J; Ozsahin H; Roosnek E. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011.

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.

Passweg JR; Zhang MJ; Rocha V; Kan F; Champlin RE; Isola LM; Gee AP; Gibson J; Laughlin MJ; Lazarus HM; Loren A; Marks DI; Gratwohl A; Eapen M. Biology of Blood and Marrow Transplantation. 2011.

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.

Eapen M; Le Rademacher J; Antin JH; Champlin RE; Carreras J; Fay J; Passweg JR; Tolar J; Horowitz MM; Marsh JC; Deeg HJ. Blood. 2011.

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.

Mohty B; Bel M; Vukicevic M; Nagy M; Levrat E; Meier S; Grillet S; Combescure C; Kaiser L; Chalandon Y; Passweg J; Siegrist CA; Roosnek E; Blood and Marrow Transplant Program; Geneva University Hospitals H1N1 study group. Haematologica. 2011.

Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.

Pradier A; Passweg J; Villard J; Kindler V. Cell transplantation. 2011.

IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

Brehm C; Huenecke S; Quaiser A; Esser R; Bremm M; Kloess S; Soerensen J; Kreyenberg H; Seidl C; Becker PS; Mühl H; Klingebiel T; Bader P; Passweg JR; Schwabe D; Koehl U. PLoS One. 2011.

Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.

Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011.

Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

de Latour, Regis Peffault; Purtill, Duncan; Ruggeri, Annalisa; Sanz, Guillermo; Michel, Gerard; Gandemer, Virginie; Maury, Sebastien; Kurtzberg, Joanne; Bonfim, Carmen; Aljurf, Mahmoud; Gluckman, Eliane; Socie, Gerard; Passweg, Jakob; Rocha, Vanderson. Biology of Blood and Marrow Transplantation. 2011.

Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.

Gratwohl A; Brand R; Niederwieser D; Baldomero H; Chabannon C; Cornelissen J; de Witte T; Ljungman P; McDonald F; McGrath E; Passweg J; Peters C; Rocha V; Slaper-Cortenbach I; Sureda A; Tichelli A; Apperley J. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011.

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

Cantoni N.; Gerull S.; Heim D.; Halter J.; Bucher C.; Buser A.; Tsakiris D.A.; Passweg J.; Tichelli A.; Stern M.; Gratwohl A.. Bone Marrow Transplantation. 2011.

Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.

Bieri S; Roosnek E; Ozsahin H; Huguet S; Ansari M; Trombetti A; Helg C; Chapuis B; Miralbell R; Passweg J; Chalandon Y. European journal of haematology. 2011.

Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.

Bizzetto R; Bonfim C; Rocha V; Socié G; Locatelli F; Chan K; Ramirez O; Stein J; Nabhan S; Miranda E; Passweg J; de Souza CA; Gluckman E; Eurocord and SAA-WP from EBMT. Haematologica. 2011.

Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.

Mueller RJ; Stussi G; Puga Yung G; Nikolic M; Soldini D; Halter J; Meyer-Monard S; Gratwohl A; Passweg JR; Odermatt B; Schanz U; Biedermann BC; Seebach JD. Haematologica. 2011.

Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow.

Matthes T; Dunand-Sauthier I; Santiago-Raber ML; Krause KH; Donze O; Passweg J; McKee T; Huard B. Blood. 2011.

The survey on cellular and engineered tissue therapies in Europe in 2009.

Martin I; Baldomero H; Bocelli-Tyndall C; Slaper-Cortenbach I; Passweg J; Tyndall A. Tissue engineering. Part A. 2011.

[Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].

Passweg JR. Therapeutische Umschau. Revue therapeutique. 2010.

ACUTE DISSEMINATED FATAL TOXOPLASMOSIS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION DESPITE ATOVAQUONE PROPHYLAXIS IN A YOUNG MAN

de la Fuente, Isabel Garcia; Ansari, Marc; Rougemont, Anne-Laure; Passweg, Jakob R.; Gumy-Pause, Fabienne; Ozsahin, Hulya; Lobrinus, Johannes A.; Posfay-Barbe, Klara M.. The Pediatric infectious disease journal. 2010.

Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA.

Risitano AM; Selleri C; Serio B; Torelli GF; Kulagin A; Maury S; Halter J; Gupta V; Bacigalupo A; Sociè G; Tichelli A; Schrezenmeier H; Marsh J; Passweg J; Rotoli B; Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology. 2010.

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

Ljungman P; Bregni M; Brune M; Cornelissen J; de Witte T; Dini G; Einsele H; Gaspar HB; Gratwohl A; Passweg J; Peters C; Rocha V; Saccardi R; Schouten H; Sureda A; Tichelli A; Velardi A; Niederwieser D; European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 2010.

Anemia as it appears to the Internist.

Tichelli A; Passweg JR. Therapeutische Umschau. Revue therapeutique. 2010.

Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation.

Passweg JR; Marsh JC. Hematology. American Society of Hematology. Education Program. 2010.

CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells.

Vukicevic M; Chalandon Y; Helg C; Matthes T; Dantin C; Huard B; Chizzolini C; Passweg J; Roosnek E. European journal of immunology. 2010.

Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.

Lebeau O; Van Delden C; Garbino J; Robert J; Lamoth F; Passweg J; Chalandon Y. Transplant infectious disease : an official journal of the Transplantation Society. 2010.

Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies.

Stussi G; Halter J; Tichelli A; Meyer-Monard S; Buser AS; Arber C; Heim D; Passweg JR; Rischewski J; Paulussen M; Gratwohl A. Bone Marrow Transplantation. 2010.

Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients.

Nabhan SK; Bitencourt MA; Duval M; Abecasis M; Dufour C; Boudjedir K; Rocha V; Socié G; Passweg J; Goi K; Sanders J; Snowden J; Yabe H; Pasquini R; Gluckman E; Aplastic Anaemia Working Party, EBMT. Haematologica. 2010.

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.

Bacigalupo A; Socie' G; Lanino E; Prete A; Locatelli F; Locasciulli A; Cesaro S; Shimoni A; Marsh J; Brune M; Van Lint MT; Oneto R; Passweg J; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2010.

Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect.

Passweg J; Baldomero H; Stern M; Bargetzi M; Ghielmini M; Leibundgut K; Duchosal M; Hess U; Seger R; Buhrfeind E; Schanz U; Gratwohl A; Swiss Blood and Marrow Stem Cells Transplant Group (SBST). Swiss medical weekly. 2010.

Hepatitis-associated aplastic anaemia: epidemiology and treatment results obtained in Europe. A report of The EBMT aplastic anaemia working party.

Locasciulli A; Bacigalupo A; Bruno B; Montante B; Marsh J; Tichelli A; Socié G; Passweg J; Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group (SAA-WP, EBMT). British Journal of Haematology. 2010.

IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.

Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U. European journal of immunology. 2010.

IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.

Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U. Journal of immunotherapy (Hagerstown, Md. : 1997). 2010.

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

Gupta V; Eapen M; Brazauskas R; Carreras J; Aljurf M; Gale RP; Hale GA; Ilhan O; Passweg JR; Ringdén O; Sabloff M; Schrezenmeier H; Socié G; Marsh JC. Haematologica. 2010.

Invasive microsporidiosis in allogeneic haematopoietic SCT recipients.

Ambrosioni J; van Delden C; Krause KH; Bouchuiguir-Wafa C; Nagy M; Passweg J; Chalandon Y. Bone Marrow Transplantation. 2010.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.

Chalandon Y; Passweg JR; Schmid C; Olavarria E; Dazzi F; Simula MP; Ljungman P; Schattenberg A; de Witte T; Lenhoff S; Jacobs P; Volin L; Iacobelli S; Finke J; Niederwieser D; Guglielmi C; Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 2010.

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

Marsh J; Socie G; Tichelli A; Schrezenmeier H; Hochsmann B; Risitano AM; Fuehrer M; Bekassy AN; Korthof ET; Locasciulli A; Ljungman P; Bacigalupo A; Camitta B; Young NS; Passweg J; European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party. British Journal of Haematology. 2010.

Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood.

Rovó A; Stüssi G; Meyer-Monard S; Favre G; Tsakiris D; Heim D; Halter J; Arber C; Passweg J; Gratwohl A; Tichelli A. International journal of laboratory hematology. 2010.

Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT.

Piccin A; McCann S; Socié G; Oneto R; Bacigalupo A; Locasciulli A; Marsh J; Schrezenmeier H; Tichelli A; Hand E; Lawler M; Passweg J; Aplastic Anaemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 2010.

[APRIL, the spring of plasmacytes].

Burjanadze M; Roosnek E; Passweg J; Huard B. M S-MEDECINE SCIENCES. 2009.

[Neuropathy associated with monoclonal gammopathy (dysglobulinemia)].

Lalive PH; Passweg JR; Kuntzer T. Revue Medicale Suisse. 2009.

Aplastic anemia and concomitant autoimmune diseases.

Stalder MP; Rovó A; Halter J; Heim D; Silzle T; Passweg J; Rischewski J; Stern M; Arber C; Buser A; Meyer-Monard S; Tichelli A; Gratwohl A. Annals of hematology. 2009.

Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma.

Rigamonti F; Beris P; Sanchez-Pareja A; Meyer P; Ashrafpoor G; Zaza S; Passweg J; Chalandon Y. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2009.

Birth order and outcome after HLA-identical sibling donor transplantation.

Gratwohl A; Doehler B; Stern M; Bucher C; Passweg J; Opelz G. Blood. 2009.

Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: report from the EBMT Paediatric Diseases and Late Effects Working Parties.

Uderzo C; Pillon M; Tridello G; Dini G; Urban C; Corti P; Zintl F; Fagioli F; Messina C; Verdeguer A; Faraci M; Fedeli S; Tana F; Tichelli A; Passweg J; Rovelli A. Pediatric transplantation. 2009.

Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation

Meyer-Monard S.; Passweg J.; Siegler U.; Kalberer C.; Koehl U.; Rovo A.; Halter J.; Stern M.; Heim D.; Alois Gratwohl J.R.; Tichelli A.. Transfusion. 2009.

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells.

Meyer-Monard S; Passweg J; Troeger C; Eberhard HP; Roosnek E; de Faveri GN; Chalandon Y; Rovo A; Kindler V; Irion O; Holzgreve W; Gratwohl A; Müller C; Tichelli A; Tiercy JM. Bone Marrow Transplantation. 2009.

Diagnosis and treatment of acquired aplastic anemia.

Bacigalupo A; Passweg J. Hematology/oncology clinics of North America. 2009.

DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.

Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M. European journal of haematology. 2009.

Hodgkin's lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back

Verholen, Frank; Terrettaz, Marianne; Roosnek, Eddy; Passweg, Jakob R.; Chalandon, Yves. European journal of haematology. 2009.

Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?

Passweg JR; Tichelli A. Haematologica. 2009.

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen.

Maury S; Bacigalupo A; Anderlini P; Aljurf M; Marsh J; Socié G; Oneto R; Passweg JR; Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT-SAAWP). Haematologica. 2009.

Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortality.

Cantoni N; Weisser M; Buser A; Arber C; Stern M; Heim D; Halter J; Christen S; Tsakiris DA; Droll A; Frei R; Widmer AF; Flückiger U; Passweg J; Tichelli A; Gratwohl A. European journal of haematology. 2009.

In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development.

Burjanadze M; Matthes T; McKee T; Passweg J; Huard B. Histology and histopathology. 2009.

Late complications after hematopoietic stem cell transplantation.

Tichelli A; Rovó A; Passweg J; Schwarze CP; Van Lint MT; Arat M; Socié G; Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Expert Rev Hematol. 2009.

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Stussi G; Halter J; Bucheli E; Valli PV; Seebach L; Gmür J; Gratwohl A; Schanz U; Passweg JR; Seebach JD. Haematologica. 2009.

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome.

Robinson SP; Sureda A; Canals C; Russell N; Caballero D; Bacigalupo A; Iriondo A; Cook G; Pettitt A; Socie G; Bonifazi F; Bosi A; Michallet M; Liakopoulou E; Maertens J; Passweg J; Clarke F; Martino R; Schmitz N; Lymphoma Working Party of the EBMT. Haematologica. 2009.

Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.

Horan JT; Carreras J; Tarima S; Camitta BM; Gale RP; Hale GA; Hinterberger W; Marsh J; Passweg JR; Walters MC; Eapen M. Biology of Blood and Marrow Transplantation. 2009.

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

Gratwohl A; Stern M; Brand R; Apperley J; Baldomero H; de Witte T; Dini G; Rocha V; Passweg J; Sureda A; Tichelli A; Niederwieser D; European Group for Blood and Marrow Transplantation and the European Leukemia Net. Cancer. 2009.

Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.

Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A; Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group. British Journal of Haematology. 2009.

Stem cell transplantation for patients with Evans syndrome

Benesch, Martin; Urban, Christian; Platzbecker, Uwe; Passweg, Jakob. EXPERT REV CLIN IMMU. 2009.

Tumors that look for their springtime in APRIL.

Roosnek E; Burjanadze M; Dietrich PY; Matthes T; Passweg J; Huard B. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2009.

[Acute leukemias].

Passweg,J R; Chalandon,Y; Matthes,T; Beris,P; Aapro,M S; Plan,P-A. Revue Medicale Suisse. 2008.

Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

Cohen EP; Irving AA; Drobyski WR; Klein JP; Passweg J; Talano JA; Juckett MB; Moulder JE. International journal of radiation oncology, biology, physics. 2008.

Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation.

Stern M; Brand R; de Witte T; Sureda A; Rocha V; Passweg J; Baldomero H; Niederwieser D; Gratwohl A. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008.

Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.

Passweg JR; Rabusin M. Autoimmunity. 2008.

In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them

Suva, Domizio; Passweg, Jakob; Arnaudeau, Serge; Hoffmeyer, Pierre; Kindler, Vincent. Journal of cellular physiology. 2008.

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; EBMT Late Effects Working Party. Haematologica. 2008.

Patient and product factors affecting platelet transfusion results.

Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A. Transfusion. 2008.

Quality of life and social integration after allogeneic hematopoietic SCT.

Bieri S; Roosnek E; Helg C; Verholen F; Robert D; Chapuis B; Passweg J; Miralbell R; Chalandon Y. Bone Marrow Transplantation. 2008.

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia.

Viollier R; Socié G; Tichelli A; Bacigalupo A; Korthof ET; Marsh J; Cornish J; Ljungman P; Oneto R; Békássy AN; Fuehrer M; Maury S; Schrezenmeier H; van Lint MT; Wojcik D; Locasciulli A; Passweg JR. Bone Marrow Transplantation. 2008.

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

Storek J; Geddes M; Khan F; Huard B; Helg C; Chalandon Y; Passweg J; Roosnek E. Seminars in immunopathology. 2008.

Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases.

Went P; Tzankov A; Schwaller J; Passweg J; Roosnek E; Huard B. Experimental Hematology. 2008.

Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.

Terrettaz M; Verholen F; Passweg J; Knipp S; Burkhard PR; Chalandon Y. Bone Marrow Transplantation. 2008.

The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders.

Theocharides A; Passweg JR; Medinger M; Looser R; Li S; Hao-Shen H; Buser AS; Gratwohl A; Tichelli A; Skoda RC. Haematologica. 2008.

AB0 blood group incompatible haematopoietic stem cell transplantation and xenograft rejection.

Stussi G; Mueller RJ; Passweg J; Schanz U; Rieben R; Seebach JD. Swiss medical weekly. 2007.

ABO blood group incompatible haematopoietic stem cell transplantation and xenograft rejection

Stussi,Georg; Mueller,Regula J; Passweg,Jakob; Schanz,Urs; Rieben,Robert; Seebach,Jörg D. Swiss medical weekly. 2007.

Autologous stem cell transplantation in autoimmune diseases.

Passweg J; Tyndall A. SEMINARS IN HEMATOLOGY. 2007.

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

Champlin RE; Perez WS; Passweg JR; Klein JP; Camitta BM; Gluckman E; Bredeson CN; Eapen M; Horowitz MM. Blood. 2007.

Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).

Socie G; Mary JY; Schrezenmeier H; Marsh J; Bacigalupo A; Locasciulli A; Fuehrer M; Bekassy A; Tichelli A; Passweg J. Blood. 2007.

High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.

Buser AS; Stern M; Bucher C; Arber C; Heim D; Halter J; Meyer-Monard S; Stussi G; Lohri A; Ghielmini M; Tichelli A; Passweg JR; Gratwohl A. Bone Marrow Transplantation. 2007.

HLA and KIR polymorphisms affect NK-cell anti-tumor activity.

Passweg JR; Huard B; Tiercy JM; Roosnek E. TRENDS IN IMMUNOLOGY. 2007.

Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantation.

Dobr T; Passweg J; Weber C; Tichelli A; Heim D; Meyer J; Gratwohl A; Waltimo T. European journal of haematology. 2007.

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

Locasciulli A; Oneto R;